{
"documentInfo": {
"documentType": "https://xbrl.org/2021/xbrl-json",
"features": {
"xbrl:canonicalValues": true
},
"namespaces": {
"grx": "http://greenxmetals.com/xbrl/2026",
"ifrs-full": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
"iso4217": "http://www.xbrl.org/2003/iso4217",
"scheme": "http://standards.iso.org/iso/17442",
"xbrl": "https://xbrl.org/2021",
"xbrli": "http://www.xbrl.org/2003/instance"
},
"taxonomy": [
"http://greenxmetals.com/xbrl/2026/213800EHCGNYSCN9T108-2026-06-30.xsd"
]
},
"facts": {
"Tag276": {
"value": "\nLevel 9, 28 The Esplanade, \nPerth WA 6000 Australia\n",
"dimensions": {
"concept": "ifrs-full:AddressOfRegisteredOfficeOfEntity",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag277": {
"value": "GreenX Metals Limited",
"dimensions": {
"concept": "ifrs-full:NameOfParentEntity",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag278": {
"value": "\nThe principal activities of \u00a0the Group during the financial year consisted of the exploration and evaluation of its \nexploration projects\u00a0and the defence of\u00a0its Award made against Poland.\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag3": {
"value": "308459.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Revenue",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag4": {
"value": "244867.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Revenue",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag5": {
"value": "1591586.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag6": {
"value": "279076.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag7": {
"value": "2243082.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ExpenseArisingFromExplorationForAndEvaluationOfMineralResources",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag8": {
"value": "723481.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ExpenseArisingFromExplorationForAndEvaluationOfMineralResources",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag9": {
"value": "913455.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:EmployeeBenefitsExpense",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag10": {
"value": "968000.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:EmployeeBenefitsExpense",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag11": {
"value": "902667.0",
"decimals": 0,
"dimensions": {
"concept": "grx:AdministrationAndCorporateExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag12": {
"value": "820478.0",
"decimals": 0,
"dimensions": {
"concept": "grx:AdministrationAndCorporateExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag13": {
"value": "520984.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OccupancyExpense",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag14": {
"value": "403516.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OccupancyExpense",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag15": {
"value": "583232.0",
"decimals": 0,
"dimensions": {
"concept": "grx:BusinessDevelopmentExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag16": {
"value": "416338.0",
"decimals": 0,
"dimensions": {
"concept": "grx:BusinessDevelopmentExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag17": {
"value": "-1373037.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ShareBasedPaymentReversalExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag18": {
"value": "-136955.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ShareBasedPaymentReversalExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag19": {
"value": "3288577.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ArbitrationRelatedExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag20": {
"value": "3077540.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ArbitrationRelatedExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag21": {
"value": "4415000.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag22": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag23": {
"value": "-12339989.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossBeforeTax",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag24": {
"value": "-6022365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossBeforeTax",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag25": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag26": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag27": {
"value": "-12339989.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag28": {
"value": "-6022365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag29": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag30": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag31": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag32": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag33": {
"value": "-12169057.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag34": {
"value": "-6152557.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag35": {
"value": "-12204736.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag36": {
"value": "-6014885.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag37": {
"value": "-135253.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag38": {
"value": "-7480.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag39": {
"value": "-12339989.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag40": {
"value": "-6022365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag41": {
"value": "-12033804.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag42": {
"value": "-6145077.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag43": {
"value": "-135253.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag44": {
"value": "-7480.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag45": {
"value": "-12169057.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag46": {
"value": "-6152557.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag1": {
"value": "-0.041",
"decimals": 4,
"dimensions": {
"concept": "ifrs-full:BasicEarningsLossPerShare",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD/xbrli:shares"
}
},
"Tag2": {
"value": "-0.0214",
"decimals": 4,
"dimensions": {
"concept": "ifrs-full:BasicEarningsLossPerShare",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD/xbrli:shares"
}
},
"Tag47": {
"value": "13417445.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag68": {
"value": "6826337.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag48": {
"value": "545528.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:TradeAndOtherCurrentReceivables",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag69": {
"value": "559586.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:TradeAndOtherCurrentReceivables",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag49": {
"value": "13962973.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag70": {
"value": "7385923.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag50": {
"value": "7045740.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:AssetsArisingFromExplorationForAndEvaluationOfMineralResources",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag71": {
"value": "10663185.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:AssetsArisingFromExplorationForAndEvaluationOfMineralResources",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag51": {
"value": "642091.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PropertyPlantAndEquipment",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag72": {
"value": "17945.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PropertyPlantAndEquipment",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag52": {
"value": "206432.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherNoncurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag73": {
"value": "218890.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherNoncurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag53": {
"value": "7894263.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag74": {
"value": "10900020.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag54": {
"value": "21857236.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Assets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag75": {
"value": "18285943.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Assets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag55": {
"value": "2318612.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:TradeAndOtherCurrentPayables",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag76": {
"value": "2347703.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:TradeAndOtherCurrentPayables",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag56": {
"value": "263608.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherCurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag77": {
"value": "533161.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherCurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag57": {
"value": "547815.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentProvisions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag78": {
"value": "777756.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentProvisions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag58": {
"value": "3130035.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag79": {
"value": "3658620.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag59": {
"value": "367148.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherNoncurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag92": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherNoncurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag60": {
"value": "283200.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentProvisions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag80": {
"value": "304576.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentProvisions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag61": {
"value": "650348.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag81": {
"value": "304576.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncurrentLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag62": {
"value": "3780383.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Liabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag82": {
"value": "3963196.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Liabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag63": {
"value": "18076853.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NetAssetsLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag83": {
"value": "14322747.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NetAssetsLiabilities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag64": {
"value": "113962053.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssuedCapital",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag84": {
"value": "95187822.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssuedCapital",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag65": {
"value": "8114196.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherReserves",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag85": {
"value": "10883812.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherReserves",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag88": {
"value": "-103948005.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:RetainedEarnings",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag90": {
"value": "-91743269.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:RetainedEarnings",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag66": {
"value": "18128244.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:EquityAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag86": {
"value": "14328365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:EquityAttributableToOwnersOfParent",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag89": {
"value": "-51391.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag91": {
"value": "-5618.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:NoncontrollingInterests",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag67": {
"value": "18076853.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag87": {
"value": "14322747.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag268": {
"value": "95187822.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag269": {
"value": "4616748.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag270": {
"value": "55806.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag271": {
"value": "6211258.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag272": {
"value": "-91743269.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag273": {
"value": "14328365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag274": {
"value": "-5618.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag275": {
"value": "14322747.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag103": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag113": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag132": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag123": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag142": {
"value": "-12204736.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag151": {
"value": "-12204736.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag161": {
"value": "-135253.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag94": {
"value": "-12339989.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag104": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag114": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag133": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag124": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag143": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag152": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag162": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag95": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag105": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag115": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag134": {
"value": "170932.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag144": {
"value": "-12204736.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag153": {
"value": "-12033804.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag163": {
"value": "-135253.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag96": {
"value": "-12169057.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag106": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag116": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag135": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag125": {
"value": "-82398.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag145": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag154": {
"value": "-82398.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag164": {
"value": "89480.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag97": {
"value": "7082.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughRecognitionOfNonControllingInterest",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag107": {
"value": "18790500.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag117": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag136": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag126": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag146": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag155": {
"value": "18790500.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag165": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag98": {
"value": "18790500.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag108": {
"value": "705455.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag118": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag137": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag127": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag147": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag156": {
"value": "705455.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag166": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag99": {
"value": "705455.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag109": {
"value": "689186.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag119": {
"value": "-689186.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag138": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag128": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag148": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag157": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag167": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag100": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughTransferOfShareBasedPaymentReserve",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag110": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag120": {
"value": "-3355000.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag139": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag129": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag235": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag158": {
"value": "-3355000.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag168": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag101": {
"value": "-3355000.0",
"decimals": 0,
"dimensions": {
"concept": "grx:IncreaseDecreaseThroughLapseOfUnvestedPerformanceRights",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag111": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag121": {
"value": "1186036.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag140": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag130": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag149": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag159": {
"value": "1186036.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag169": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag102": {
"value": "1186036.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag112": {
"value": "113962053.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag122": {
"value": "1758598.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag141": {
"value": "226738.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag131": {
"value": "6128860.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag150": {
"value": "-103948005.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag160": {
"value": "18128244.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag170": {
"value": "-51391.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag93": {
"value": "18076853.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag171": {
"value": "89918183.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag172": {
"value": "4560793.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag173": {
"value": "185998.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag174": {
"value": "6211258.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag175": {
"value": "-85728384.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag176": {
"value": "15147848.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag177": {
"value": "1862.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag178": {
"value": "15149710.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag179": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag180": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag181": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag182": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag183": {
"value": "-6014885.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag184": {
"value": "-6014885.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag185": {
"value": "-7480.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag186": {
"value": "-6022365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProfitLoss",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag187": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag188": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag189": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag190": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag191": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag192": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag193": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag194": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag195": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag196": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag197": {
"value": "-130192.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag198": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag199": {
"value": "-6014885.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag200": {
"value": "-6145077.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag201": {
"value": "-7480.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag202": {
"value": "-6152557.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ComprehensiveIncome",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag203": {
"value": "5465623.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag204": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag205": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag206": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag207": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag208": {
"value": "5465623.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag209": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag210": {
"value": "5465623.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IssueOfEquity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag211": {
"value": "195984.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag212": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag213": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag214": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag215": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag216": {
"value": "195984.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag217": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag218": {
"value": "195984.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ShareIssueRelatedCost",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag219": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag220": {
"value": "55955.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag221": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag222": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag223": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag224": {
"value": "55955.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag225": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag226": {
"value": "55955.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag227": {
"value": "95187822.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
"unit": "iso4217:AUD"
}
},
"Tag228": {
"value": "4616748.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfSharebasedPaymentsMember",
"unit": "iso4217:AUD"
}
},
"Tag229": {
"value": "55806.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
"unit": "iso4217:AUD"
}
},
"Tag230": {
"value": "6211258.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherEquityInterestMember",
"unit": "iso4217:AUD"
}
},
"Tag231": {
"value": "-91743269.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
"unit": "iso4217:AUD"
}
},
"Tag232": {
"value": "14328365.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
"unit": "iso4217:AUD"
}
},
"Tag233": {
"value": "-5618.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
"unit": "iso4217:AUD"
}
},
"Tag234": {
"value": "14322747.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:Equity",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag236": {
"value": "5929391.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag248": {
"value": "4293167.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag237": {
"value": "280135.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:InterestReceivedClassifiedAsOperatingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag249": {
"value": "235863.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:InterestReceivedClassifiedAsOperatingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag238": {
"value": "1591586.0",
"decimals": 0,
"dimensions": {
"concept": "grx:RecoupmentOfArbitrationCosts",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag261": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:RecoupmentOfArbitrationCosts",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag239": {
"value": "2188322.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsForExplorationAndEvaluationExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag250": {
"value": "723443.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsForExplorationAndEvaluationExpenses",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag262": {
"value": "-6245992.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag264": {
"value": "-4780747.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag240": {
"value": "18118.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag251": {
"value": "4020.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag241": {
"value": "685716.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PurchaseOfExplorationAndEvaluationAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag252": {
"value": "783473.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PurchaseOfExplorationAndEvaluationAssets",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag260": {
"value": "0.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ReceiptsFromBHPXplorFunding",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag253": {
"value": "790071.0",
"decimals": 0,
"dimensions": {
"concept": "grx:ReceiptsFromBHPXplorFunding",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag263": {
"value": "-703834.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag254": {
"value": "2578.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag242": {
"value": "14095000.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProceedsFromIssueOfOrdinaryShares",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag255": {
"value": "4628036.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:ProceedsFromIssueOfOrdinaryShares",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag243": {
"value": "222589.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsForShareIssueCosts",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag256": {
"value": "144397.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsForShareIssueCosts",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag244": {
"value": "331477.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag257": {
"value": "49926.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag245": {
"value": "13540934.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag258": {
"value": "4433713.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag246": {
"value": "6591108.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag265": {
"value": "-344456.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00/2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag267": {
"value": "6826337.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag266": {
"value": "7170793.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2024-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag247": {
"value": "13417445.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2026-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag259": {
"value": "6826337.0",
"decimals": 0,
"dimensions": {
"concept": "ifrs-full:CashAndCashEquivalents",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00",
"unit": "iso4217:AUD"
}
},
"Tag279": {
"value": "\n1. STATEMENT OF MATERIAL ACCOUNTING POLICIES
\nThe material accounting policies adopted in preparing the financial report of GreenX Metals Limited (GreenX or
\nCompany) and its consolidated entities (Consolidated Entity or Group) for the year ended 30 June 2026 are stated
\nto assist in a general understanding of the financial report.
\nGreenX Metals is a Company limited by shares incorporated and domiciled in Australia whose shares are publicly
\ntraded on the Australian Securities Exchange (ASX), the London Stock Exchange (LSE) and the Warsaw Stock
\nExchange (WSE).
\n\n
The financial report of the Group for the year ended 30 June 2026 was authorised for issue in accordance with a
\n
resolution of the Directors.
\n
\n\n
\n
(a) Basis of Preparation
\n
The financial report is a general purpose financial report, which has been prepared in accordance with Australian
\n
Accounting Standards (AASBs) and other authoritative pronouncements of the Australian Accounting Standards
\n
Board (AASB) and the Corporations Act 2001. The Group is a for-profit entity for the purposes of preparing the
\n
consolidated financial statements.
\n
The financial report has been prepared on a historical cost basis, except for certain financial liabilities which have
\n
been measured at fair value. The financial report is presented in Australian dollars.
\n
The consolidated financial statements have been prepared on a going concern basis which assumes the continuity
\n
of normal business activity and the realisation of assets and the settlement of liabilities in the ordinary course of
\n
business.
\n
\n\n
\n
\n
(b) Statement of Compliance
\n
The financial report complies with International Financial Reporting Standards (IFRS) as issued by the
\n
International Accounting Standards Board.
\n
\n
In the current year, the Group has adopted all of the new and revised Standards and Interpretations issued by the
\n
AASB that are relevant to its operations and effective for the current annual reporting period. The adoption of these
\n
new and revised Standards or Interpretations has had an immaterial impact (if any) on the Group. Any new or
\n
amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.
\n
Australian Accounting Standards and Interpretations that have recently been issued or amended but are not yet
\n
effective have not been adopted by the Group for the annual reporting period ended 30 June 2026. Those which
\n
may be relevant to the Group are set out in the table below, but these are not expected to have any significant
\n
impact on the Group\u2019s financial statements as detailed below.
\n
\n
Standard/Interpretation
\n
Application
\n
date of
\n
standard
\n
Application
\n
date for Group
\n
AASB 2024-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\n
Instruments
\n
1 January 2026
\n
1 July 2026
\n
AASB 2024-3 Amendments to AASs \u2013 Annual Improvements Volume II. Amendments to
\n
AASB 1, AASB 7, AASB 9, AASB 10 and AASB 107
\n
1 January 2026
\n
1 July 2026
\n
AASB 2025-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\n
Instruments: Tier 2 Disclosures
\n
1 January 2026
\n
1 July 2026
\n
AASB 18 Presentation and Disclosure in Financial Statements
\n
1 January 2027
\n
1 July 2027
\n
\n\n
\n
\n\n
\n\n\n
\n
\n
\n
\n
\n\n
\n
\n
(c) Principles of Consolidation
\n
The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of the Company as at
\n
30 June 2026 and the results of all subsidiaries for the year then ended.
\n
Subsidiaries are all entities (including structured entities) over which the Group has control. The Group controls an
\n
entity when the group is exposed to, or has rights to, variable returns from its involvement with the entity and has
\n
the ability to affect those returns through its power to direct the activities of the entity.
\n
The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using
\n
consistent accounting policies. Accounting policies of subsidiaries have been changed where necessary to ensure
\n
consistency with the policies adopted by the Company.
\n
Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are de-
\n
consolidated from the date that control ceases. Intercompany transactions and balances, income and expenses
\n
and profits and losses between Group companies, are eliminated.
\n
\n\n
\n
\n\n
\n
(d) Cash and Cash Equivalents
\n
Cash and cash equivalents include cash on hand, deposits held at call with banks and other short-term highly
\n
liquid investments with original maturities of three months or less.
\n
\n\n
\n
(e) Trade and Other Receivables
\n
Trade receivables are initially recognised at the transaction price and subsequently measured at amortised costs
\n
amount less any expected credit loss (ECL).
\n
Receivables from related parties are initially recognised at fair value and measured at amortised cost and are
\n
interest free.
\n
The Group\u2019s trade and other receivables includes GST and other taxes receivables, interest receivable and security
\n
deposits.
\n
\n\n
\n
\n
\n
(f) Financial Assets
\n
(i) Initial recognition and measurement
\n
Financial assets are classified, at initial recognition, as subsequently measured at amortised cost, fair value through
\n
other comprehensive income (OCI), and fair value through profit or loss.
\n
The classification of financial assets at initial recognition depends on the financial asset\u2019s contractual cash flow
\n
characteristics and the Group\u2019s business model for managing them. The Group initially measures a financial asset
\n
at its fair value plus, in the case of a financial asset not at fair value through profit or loss, less transaction costs.
\n
(ii) Subsequent measurement
\n
For purposes of subsequent measurement, financial assets are classified in four categories:
\n
\u2022 Financial assets at amortised cost;
\n
\u2022 Financial assets at fair value through OCI with recycling of cumulative gains and losses (not relevant to the
\n
Group);
\n
\u2022 Financial assets designated at fair value through OCI with no recycling of cumulative gains and losses upon
\n
derecognition (equity instruments \u2013 not relevant to the Group); and
\n
\u2022 Financial assets at fair value through profit or loss (equity instruments \u2013 not relevant to the Group).
\n
Financial assets at amortised cost (debt instruments)
\n
The Group measures financial assets at amortised cost if both of the following conditions are met:
\n
\u2022 The financial asset is held within a business model with the objective to hold financial assets in order to
\n
collect contractual cash flows; and
\n
\u2022 The contractual terms of the financial asset give rise on specified dates to cash flows that are solely
\n
payments of principal and interest on the principal amount outstanding.
\n
Financial assets at amortised cost are subsequently measured using the effective interest rate (EIR) method and
\n
are subject to impairment. Gains and losses are recognised in profit or loss when the asset is derecognised,
\n
modified or impaired.
\n
\n\n
\n
\n\n
\n\n\n
\n
\n
\n\n
\n
\n
\n
\n
Impairment
\n
The Group recognises an allowance for ECLs for all debt instruments not held at fair value through profit or loss.
\n
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all
\n
the cash flows that the Group expects to receive, discounted at an approximation of the original EIR. ECLs are
\n
recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk
\n
since initial recognition, ECLs are provided for credit losses that result from default events that are possible within
\n
the next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in
\n
credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of
\n
the exposure, irrespective of the timing of the default (a lifetime ECL).
\n
For receivables due in less than 12 months, the Group recognises a loss allowance based on the financial asset\u2019s
\n
lifetime ECL at each reporting date.
\n
Given the nature of financial assets held by the Group, it considers a financial asset to be in default when internal
\n
or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full
\n
before taking into account any credit enhancements held by the Group. A financial asset is written off when there
\n
is no reasonable expectation of recovering the contractual cash flows.
\n
At each reporting date, the Group assesses whether financial assets carried at amortised cost are credit impaired.
\n
A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated
\n
future cash flows of the financial asset have occurred.
\n
\n\n
\n
\n\n
\n
\n\n
\n
\n
(g) Property, Plant and Equipment
\n
(i) Recognition and measurement
\n
Property, plant and equipment is stated at historical cost less accumulated depreciation and any accumulated
\n
impairment losses. Such cost includes the cost of replacing parts that are eligible for capitalisation when the cost
\n
of replacing the parts is incurred. Similarly, when each major inspection is performed, its cost is recognised in the
\n
carrying amount of the property, plant and equipment as a replacement only if it is eligible for capitalisation. All
\n
other repairs and maintenance are recognised in the Statement of Profit or Loss and other Comprehensive Income
\n
as incurred.
\n
\n
(ii) Depreciation
\n
Depreciation is provided on a straight-line basis on all property, plant and equipment.
\n
\n
2026
\n
2025
\n
Major depreciation periods (per annum) are:
\n
\n
\n
Plant and equipment:
\n
22% - 40%
\n
22% - 40%
\n
The assets\u2019 residual values, useful lives and amortisation methods are reviewed, and adjusted if appropriate, at
\n
each financial year end.
\n
\n\n
\n
(iii) Derecognition
\n
An item of property, plant and equipment is derecognised upon disposal or when no further future economic
\n
benefits are expected from its use or disposal. Impairment of property, plant and equipment are discussed in note
\n
1(s).
\n
\n\n
\n
(h) Exploration and Evaluation Expenditure
\n
Expenditure on exploration and evaluation is accounted for in accordance with the \u2018area of interest\u2019 method.
\n
Exploration and evaluation expenditure encompasses expenditures incurred by the Group in connection with the
\n
exploration for and evaluation of mineral resources before the technical feasibility and commercial viability of
\n
extracting a mineral resource are demonstrable.
\n
For each area of interest, expenditure incurred in the acquisition of rights to explore is capitalised, classified as
\n
tangible or intangible, and recognised as an exploration and evaluation asset. Exploration and evaluation assets
\n
are measured at cost at recognition and are recorded as an asset if:
\n
(i) the rights to tenure of the area of interest are current; and
\n
(ii) at least one of the following conditions is also met:
\n
\u2022 the exploration and evaluation expenditures are expected to be recouped through successful
\n
development and exploitation of the area of interest, or alternatively, by its sale; and
\n
\u2022 exploration and evaluation activities in the area of interest have not at the reporting date reached a stage
\n
which permits a reasonable assessment of the existence or otherwise of economically recoverable
\n
reserves, and active and significant operations in, or in relation to, the area of interest are continuing.
\n
Exploration and evaluation expenditure incurred by the Group subsequent to acquisition of the rights to explore
\n
is expensed as incurred, up to costs associated with the preparation of a feasibility study.
\n
\n\n
\n\n\n\n
Impairment
\n
Capitalised exploration costs are reviewed each reporting date to establish whether an indication of impairment
\n
exists. If any such indication exists, the recoverable amount of the capitalised exploration costs is estimated to
\n
determine the extent of the impairment loss (if any). Where an impairment loss subsequently reverses, the
\n
carrying amount of the asset is increased to the revised estimate of its recoverable amount, but only to the extent
\n
that the increased carrying amount does not exceed the carrying amount that would have been determined had
\n
no impairment loss been recognised for the asset in previous years.
\n
Where a decision is made to proceed with development, accumulated expenditure is tested for impairment and
\n
transferred to development properties, and then amortised over the life of the reserves associated with the area
\n
of interest once mining operations have commenced. Recoverability of the carrying amount of the exploration
\n
and evaluation assets is dependent on successful development and commercial exploitation, or alternatively, sale
\n
of the respective areas of interest.
\n
Grant funding receivable
\n
Where funds are received or receivable from partners regarding monetary contributions for project identification,
\n
validation or exploration, the funds received are allocated in the financial statements against the corresponding
\n
expense or exploration asset.
\n
\n\n
\n
(i) Payables
\n
Liabilities are recognised for amounts to be paid in the future for goods and services received. Trade accounts
\n
payable are normally settled within 30 days. Payables are carried at amortised cost.
\n
\n\n
\n
(j) Provisions
\n
Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past
\n
event, it is probable that an outflow of resources embodying economic benefits will be required to settle the
\n
obligation and a reliable estimate can be made of the amount of the obligation.
\n
Provisions are measured at the present value of management\u2019s best estimate of the expenditure required to settle
\n
the present obligation at the reporting date. If the effect of the time value of money is material, provisions are
\n
discounted using a current pre-tax rate that reflects, when appropriate, the risks specific to the liability. When
\n
discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
\n
\n\n
\n
\n
\n
\n
(k) Financial Liabilities
\n
(i) Initial recognition and measurement
\n
Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans
\n
and borrowings (amortised cost) or payables.
\n
All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables,
\n
net of directly attributable transaction costs.
\n
The Group\u2019s financial liabilities include trade and other payables and financial liabilities at fair value through profit
\n
or loss.
\n
(ii) Subsequent measurement
\n
The measurement of financial liabilities depends on their classification, as described below:
\n
Amortised cost liabilities
\n
This is the category most relevant to the Group. After initial recognition, amortised cost liabilities are subsequently
\n
measured at amortised cost using the EIR method. Gains and losses are then recognised in profit or loss when the
\n
liabilities are derecognised as well as through the EIR amortisation process.
\n
Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that
\n
are an integral part of the EIR. The EIR amortisation is included as finance costs in the statement of profit or loss.
\n
\n
Financial liabilities at fair value through profit or loss
\n
This is the category least relevant to the Group. Financial liabilities at fair value through profit or loss include
\n
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value
\n
through profit or loss.
\n
Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near
\n
term.
\n
Financial liabilities at fair value through profit or loss
\n
Gains or losses on liabilities held for trading are recognised in the statement of profit or loss.
\n
Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the
\n
initial date of recognition, and only if the criteria in AASB 9 Financial Instruments are satisfied.
\n
\n\n
\n
\n\n
\n
\n\n
\n
\n
\n
\n
\n\n
\n
\n
\n
\n
(iii) Derecognition
\n
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.
\n
When an existing financial liability is replaced by another on substantially different terms, or the terms of an
\n
existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the
\n
original liability and the recognition of a new liability. The difference in the respective carrying amounts is
\n
recognised in the statement of profit or loss.
\n
\n\n
\n
\n\n
\n
\n\n
\n
(l) Revenue Recognition
\n
Revenue is recognised when control of goods is transferred to the customer at an amount that reflects the
\n
consideration to which the Group expects to be entitled to in exchange for those goods.
\n
Interest revenue is recognised as it accrues, taking into account the effective yield on the financial asset.
\n
\n\n
\n
\n
(m) Income Tax
\n
The income tax expense for the period is the tax payable on the current period\u2019s taxable income based on the
\n
national income tax rate for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable
\n
to temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial
\n
statements, and to unused tax losses.
\n
\n
Deferred tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when
\n
the assets are recovered or liabilities are settled, based on those tax rates which are enacted or substantively
\n
enacted at balance date for each jurisdiction. The relevant tax rates are applied to the cumulative amounts of
\n
deductible and taxable temporary differences to measure the deferred tax asset or liability. An exception is made
\n
for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax asset
\n
or liability is recognised in relation to these temporary differences if they arose on goodwill or in a transaction,
\n
other than a business combination, that at the time of the transaction did not affect either accounting profit or
\n
taxable profit or loss.
\n
Deferred tax liabilities and assets are not recognised for temporary differences between the carrying amount and
\n
tax bases of investments in controlled entities where the Company is able to control the timing of the reversal of
\n
the temporary differences and it is probable that the differences will not reverse in the foreseeable future.
\n
Deferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable
\n
that future taxable amounts will be available to utilise those temporary differences and losses.
\n
The carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent
\n
that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income
\n
tax asset to be utilised.
\n
Unrecognised deferred income tax assets are reassessed at each balance date and are recognised to the extent
\n
that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
\n
Current and deferred tax balances attributable to amounts recognised directly in equity are also recognised
\n
directly in equity.
\n
Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current
\n
tax assets against tax liabilities and the deferred tax liabilities relate to the same taxable entity and the same
\n
taxation authority.
\n
\n\n
\n
(n) Tax consolidation
\n
GreenX Metals Limited and its wholly-owned Australian subsidiaries have formed an income tax consolidated
\n
group under the tax consolidation regime. Each entity in the tax consolidated group recognises its own current
\n
and deferred tax liabilities, except for any deferred tax assets resulting from unused tax losses and tax credits,
\n
which are immediately assumed by the Company (which is the head entity in the tax consolidated group). The
\n
current tax liability of each group entity is then subsequently assumed by the Company. The tax consolidated
\n
group has entered a tax sharing agreement whereby each company in the Group contributes to the income tax
\n
payable in proportion to their contribution to the net profit before tax of the tax consolidated group.
\n
\n\n
\n
(o) Employee Entitlements
\n
Provision is made for the Group\u2019s liability for employee benefits arising from services rendered by employees to
\n
balance date. Employee benefits that are expected to be settled within 12 months have been measured at the
\n
amounts expected to be paid when the liability is settled, plus related on-costs. Employee benefits payable later
\n
than 12 months have been measured using the projected unit credit valuation method.
\n
\n\n
\n
(p) Earnings per Share
\n
Basic earnings per share (EPS) is calculated by dividing the net profit attributable to members of the Company for
\n
the reporting period, after excluding any costs of servicing equity, by the weighted average number of Ordinary
\n
Shares of the Company, adjusted for any bonus issue.
\n
\n\n
\n\n\n\n
Diluted EPS is calculated by dividing the basic EPS earnings, adjusted by the after tax effect of financing costs
\n
associated with dilutive potential Ordinary Shares and the effect on revenues and expenses of conversion to
\n
Ordinary Shares associated with dilutive potential Ordinary Shares, by the weighted average number of Ordinary
\n
Shares and dilutive Ordinary Shares adjusted for any bonus issue.
\n
\n\n
\n
(q) Goods and Services Tax (GST)
\n
Revenues, expenses and assets are recognised net of the amount of GST, except where the amount of GST incurred
\n
is not recoverable from the Australian Tax Office. In these circumstances the GST is recognised as part of the cost
\n
of acquisition of the asset or as part of the expense. Receivables and payables in the statement of financial position
\n
are shown inclusive of GST.
\n
Cash flows are presented in the cash flow statement on a gross basis, except for the GST component of investing
\n
and financing activities, which are disclosed as operating cash flows.
\n
\n\n
(r) Acquisition of Assets
\nA group of assets may be acquired in a transaction which is not a business combination. In such cases the cost of
\nacquisition is allocated to the individual identifiable assets (including intangible assets that meet the definition of
\nand recognition criteria for intangible assets in AASB 138) acquired and liabilities assumed on the basis of their
\nrelative fair values at the date of purchase.
\n\n
(s) Impairment of non-current Assets
\n
The Group assesses at each reporting date whether there is an indication that a non-current asset may be
\n
impaired. If any such indication exists, or when annual impairment testing for an asset is required, the Group
\n
makes an estimate of the asset's recoverable amount. An asset's recoverable amount is the higher of its fair value
\n
less costs of disposal and its value in use and is determined for an individual asset, unless the asset does not
\n
generate cash inflows that are largely independent of those from other assets or groups of assets and the asset's
\n
value in use cannot be estimated to be close to its fair value. In such cases the asset is tested for impairment as
\n
part of the cash-generating unit to which it belongs. When the carrying amount of an asset or cash-generating
\n
unit exceeds its recoverable amount, the asset or cash-generating unit is considered impaired and is written down
\n
to its recoverable amount.
\n
In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax
\n
discount rate that reflects current market assessments of the time value of money and the risks specific to the
\n
asset.
\n
An assessment is also made at each reporting date as to whether there is any indication that previously recognised
\n
impairment losses may no longer exist or may have decreased. If such indication exists, the recoverable amount is
\n
estimated. A previously recognised impairment loss is reversed only if there has been a change in the estimates
\n
used to determine the asset's recoverable amount since the last impairment loss was recognised. If that is the case
\n
the carrying amount of the asset is increased to its recoverable amount.
\n
That increased amount cannot exceed the carrying amount that would have been determined, net of
\n
depreciation, had no impairment loss been recognised for the asset in prior years. Such reversal is recognised in
\n
profit or loss. After such a reversal the depreciation charge is adjusted in future periods to allocate the asset's
\n
revised carrying amount, less any residual value, on a systematic basis over its remaining useful life.
\n
\n\n
\n
(t) Fair Value Estimation
\n
The fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for
\n
disclosure purposes.
\n
The fair value of financial instruments traded in active markets is based on quoted market prices at the reporting
\n
date. The quoted market price used for financial assets held by the Group is the current bid price; the appropriate
\n
quoted market price for financial liabilities is the current ask price.
\n
The net carrying value of trade receivables and payables are short term in nature and approximate their fair values.
\n
The fair value of financial liabilities for disclosure purposes is estimated by discounting the future contractual cash
\n
flows at the current market interest rate that is available to the Group for similar financial instruments.
\n
\n\n
\n
(u) Issued and Unissued Capital
\n
Ordinary Shares are classified as equity. Issued and paid up capital is recognised at the fair value of the
\n
consideration received by the Company. Incremental costs directly attributable to the issue of new shares or
\n
options are shown in equity as a deduction, net of tax, from the proceeds.
\n
\n\n
\n
\n
(v) Foreign Currencies
\n
\n
(i) Functional and presentation currency
\n
The functional currency of each of the Group's entities is measured using the currency of the primary economic
\n
environment in which that entity operates. The consolidated financial statements are presented in Australian
\n
dollars which is the Company's functional and presentation currency.
\n
\n\n
\n
\n\n
\n
\n
\n\n
Transactions and balances
\n
Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the
\n
date of the transaction. Foreign currency monetary items are translated at the year-end exchange rate. Non-
\n
monetary items measured at historical cost continue to be carried at the exchange rate at the date of the
\n
transaction.
\n
Exchange differences arising on the translation of monetary items are recognised in the Statement Profit or Loss
\n
and other Comprehensive Income.
\n
Exchange differences arising on the translation of non-monetary items are recognised directly in equity to the
\n
extent that the gain or loss is directly recognised in equity, otherwise the exchange difference is recognised in the
\n
other Comprehensive Income.
\n
(ii) Group companies
\n
The financial results and position of foreign operations whose functional currency is different from the Group's
\n
presentation currency are translated as follows:
\n
\u2022 assets and liabilities are translated at year-end exchange rates prevailing at that reporting date;
\n
\u2022 income and expenses are translated at average exchange rates for the period; and
\n
\u2022 items of equity are translated at the historical exchange rates prevailing at the date of the transaction.
\n
Exchange differences arising on translation of foreign operations are transferred to the group's foreign currency
\n
translation reserve in the Statement of Financial Position. The accumulated difference is reclassified in the
\n
Statement of Profit or Loss and other Comprehensive Income in the period in which the operation is disposed.
\n
\n\n
\n
(w) Share-Based Payments
\n
Equity-settled share-based payments are provided to officers, employees, consultants and other advisors. These
\n
share-based payments are measured at the fair value of the equity instrument at the grant date. Fair value is
\n
determined using the Binomial option pricing model. Further details on how the fair value of equity-settled share-
\n
based payments has been determined can be found in Note 19.
\n
The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on
\n
the Company's estimate of equity instruments that will eventually vest. At each reporting date, the Company
\n
revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original
\n
estimates, if any, is recognised in profit or loss over the remaining vesting period, with a corresponding adjustment
\n
to the option premium reserve.
\n
Equity-settled share-based payments may also be provided as consideration for the acquisition of assets. Where
\n
Ordinary Shares are issued, the transaction is recorded at fair value based on the quoted price of the Ordinary
\n
Shares at the grant date. The acquisition is then recorded as an asset or expensed in accordance with accounting
\n
standards. Unvested incentive securities that lapse when non-market conditions are not met are reversed from
\n
the share-based payment reserve to the Statement of Profit or Loss.
\n
\n\n
(x) Arbitration facility income
\nArbitration facility income is recognised when there is reasonable assurance that the Company will comply with
\nthe LFA and the benefits will be received. Arbitration facility income is recognised in profit or loss on a systematic
\nbasis over the periods in which the entity recognises as expenses the related arbitration costs for which the income
\nis intended to compensate.
\n\n
(y) Use and Revision of Accounting Estimates, Judgements and Assumptions
\n
The preparation of the financial report requires management to make judgements, estimates and assumptions
\n
that affect the application of accounting policies and the reported amounts of assets, liabilities, income and
\n
expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed
\n
on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is
\n
revised if the revision affects only that period, or in the period of the revision and future periods if the revision
\n
affects both current and future periods.
\n
In particular, information about significant areas of estimation uncertainty and critical judgements in applying
\n
accounting policies that have the most significant effect on the amount recognised in the financial statements
\n
are described in the following notes:
\n
\u2022 Share-Based Payments (Note 19) - The Group initially measures the cost of equity-settled transactions with
\n
employees by reference to the fair value of the equity instrument at the date at which they are granted.
\n
Estimating fair value for share-based payment transactions requires the determination of the most
\n
appropriate valuation model. This estimate also requires the determination of the most appropriate inputs
\n
to the valuation model including the expected life of the share option, volatility and dividend yield. The
\n
assumption and models used for estimating the fair value for share-based payment transactions are
\n
disclosed in Note 19.
\n
\n\n
\n\n\n\n
\u2022 Functional currency of foreign operations (Note 22 (g)) - determination of the functional currency of foreign
\n
subsidiaries requires judgement regarding the primary currency of labour, material and exploration spend
\n
in that subsidiary.
\n
\u2022 Exploration and Evaluation Assets (Note 6) \u2013 the Group\u2019s accounting policy for exploration and evaluation
\n
assets is set out in Note 1(h). The application of this policy requires management to make certain
\n
judgements and estimates as to future events and circumstances, in particular, the assessment of whether
\n
economic quantities of reserves have been found and the point at which exploration and evaluation assets
\n
should be transferred to mine development properties. The determination of an area of interest also
\n
requires judgement.
\n
\n\n
(z) Leases
\nThe Group assesses at contract inception whether a contract is, or contains, a lease. That is, if the contract conveys
\nthe right to control the use of an identified asset for a period of time in exchange for consideration.
\nThe Group applies a single recognition and measurement approach for all leases, except for short-term leases and
\nleases of low-value assets. The Group recognises lease liabilities to make lease payments and right-of-use assets
\nrepresenting the right to use the underlying assets.
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag281": {
"value": "GreenX Metals Limited",
"dimensions": {
"concept": "ifrs-full:NameOfReportingEntityOrOtherMeansOfIdentification",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag282": {
"value": "limited by shares",
"dimensions": {
"concept": "ifrs-full:LegalFormOfEntity",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag283": {
"value": "Australia",
"dimensions": {
"concept": "ifrs-full:DomicileOfEntity",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag280": {
"value": "\nThe financial report of the Group for the year ended 30 June 2026 was authorised for issue in accordance with a
\nresolution of the Directors.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag284": {
"value": "\n(a) Basis of Preparation
\nThe financial report is a general purpose financial report, which has been prepared in accordance with Australian
\nAccounting Standards (AASBs) and other authoritative pronouncements of the Australian Accounting Standards
\nBoard (AASB) and the Corporations Act 2001. The Group is a for-profit entity for the purposes of preparing the
\nconsolidated financial statements.
\nThe financial report has been prepared on a historical cost basis, except for certain financial liabilities which have
\nbeen measured at fair value. The financial report is presented in Australian dollars.
\nThe consolidated financial statements have been prepared on a going concern basis which assumes the continuity
\nof normal business activity and the realisation of assets and the settlement of liabilities in the ordinary course of
\nbusiness.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag285": {
"value": "\n
\n(b) Statement of Compliance
\nThe financial report complies with International Financial Reporting Standards (IFRS) as issued by the
\nInternational Accounting Standards Board.
\n\n
In the current year, the Group has adopted all of the new and revised Standards and Interpretations issued by the
\n
AASB that are relevant to its operations and effective for the current annual reporting period. The adoption of these
\n
new and revised Standards or Interpretations has had an immaterial impact (if any) on the Group. Any new or
\n
amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.
\n
Australian Accounting Standards and Interpretations that have recently been issued or amended but are not yet
\n
effective have not been adopted by the Group for the annual reporting period ended 30 June 2026. Those which
\n
may be relevant to the Group are set out in the table below, but these are not expected to have any significant
\n
impact on the Group\u2019s financial statements as detailed below.
\n
\n
Standard/Interpretation
\n
Application
\n
date of
\n
standard
\n
Application
\n
date for Group
\n
AASB 2024-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\n
Instruments
\n
1 January 2026
\n
1 July 2026
\n
AASB 2024-3 Amendments to AASs \u2013 Annual Improvements Volume II. Amendments to
\n
AASB 1, AASB 7, AASB 9, AASB 10 and AASB 107
\n
1 January 2026
\n
1 July 2026
\n
AASB 2025-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\n
Instruments: Tier 2 Disclosures
\n
1 January 2026
\n
1 July 2026
\n
AASB 18 Presentation and Disclosure in Financial Statements
\n
1 January 2027
\n
1 July 2027
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:StatementOfIFRSCompliance",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag286": {
"value": "\nIn the current year, the Group has adopted all of the new and revised Standards and Interpretations issued by the
\nAASB that are relevant to its operations and effective for the current annual reporting period. The adoption of these
\nnew and revised Standards or Interpretations has had an immaterial impact (if any) on the Group. Any new or
\namended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.
\nAustralian Accounting Standards and Interpretations that have recently been issued or amended but are not yet
\neffective have not been adopted by the Group for the annual reporting period ended 30 June 2026. Those which
\nmay be relevant to the Group are set out in the table below, but these are not expected to have any significant
\nimpact on the Group\u2019s financial statements as detailed below.
\n
\nStandard/Interpretation
\nApplication
\ndate of
\nstandard
\nApplication
\ndate for Group
\nAASB 2024-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\nInstruments
\n1 January 2026
\n1 July 2026
\nAASB 2024-3 Amendments to AASs \u2013 Annual Improvements Volume II. Amendments to
\nAASB 1, AASB 7, AASB 9, AASB 10 and AASB 107
\n1 January 2026
\n1 July 2026
\nAASB 2025-2 Amendments to AASs \u2013 Classification and Measurement of Financial
\nInstruments: Tier 2 Disclosures
\n1 January 2026
\n1 July 2026
\nAASB 18 Presentation and Disclosure in Financial Statements
\n1 January 2027
\n1 July 2027
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag288": {
"value": "\n
\n\n
(c) Principles of Consolidation
\n
The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of the Company as at
\n
30 June 2026 and the results of all subsidiaries for the year then ended.
\n
Subsidiaries are all entities (including structured entities) over which the Group has control. The Group controls an
\n
entity when the group is exposed to, or has rights to, variable returns from its involvement with the entity and has
\n
the ability to affect those returns through its power to direct the activities of the entity.
\n
The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using
\n
consistent accounting policies. Accounting policies of subsidiaries have been changed where necessary to ensure
\n
consistency with the policies adopted by the Company.
\n
Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are de-
\n
consolidated from the date that control ceases. Intercompany transactions and balances, income and expenses
\n
and profits and losses between Group companies, are eliminated.
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag289": {
"value": "\n(c) Principles of Consolidation
\nThe consolidated financial statements incorporate the assets and liabilities of all subsidiaries of the Company as at
\n30 June 2026 and the results of all subsidiaries for the year then ended.
\nSubsidiaries are all entities (including structured entities) over which the Group has control. The Group controls an
\nentity when the group is exposed to, or has rights to, variable returns from its involvement with the entity and has
\nthe ability to affect those returns through its power to direct the activities of the entity.
\nThe financial statements of the subsidiaries are prepared for the same reporting period as the Company, using
\nconsistent accounting policies. Accounting policies of subsidiaries have been changed where necessary to ensure
\nconsistency with the policies adopted by the Company.
\nSubsidiaries are fully consolidated from the date on which control is transferred to the Company. They are de-
\nconsolidated from the date that control ceases. Intercompany transactions and balances, income and expenses
\nand profits and losses between Group companies, are eliminated.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag290": {
"value": "\n(d) Cash and Cash Equivalents
\nCash and cash equivalents include cash on hand, deposits held at call with banks and other short-term highly
\nliquid investments with original maturities of three months or less.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag291": {
"value": "\n(e) Trade and Other Receivables
\nTrade receivables are initially recognised at the transaction price and subsequently measured at amortised costs
\namount less any expected credit loss (ECL).
\nReceivables from related parties are initially recognised at fair value and measured at amortised cost and are
\ninterest free.
\nThe Group\u2019s trade and other receivables includes GST and other taxes receivables, interest receivable and security
\ndeposits.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag292": {
"value": "\n
\n\n
(f) Financial Assets
\n
(i) Initial recognition and measurement
\n
Financial assets are classified, at initial recognition, as subsequently measured at amortised cost, fair value through
\n
other comprehensive income (OCI), and fair value through profit or loss.
\n
The classification of financial assets at initial recognition depends on the financial asset\u2019s contractual cash flow
\n
characteristics and the Group\u2019s business model for managing them. The Group initially measures a financial asset
\n
at its fair value plus, in the case of a financial asset not at fair value through profit or loss, less transaction costs.
\n
(ii) Subsequent measurement
\n
For purposes of subsequent measurement, financial assets are classified in four categories:
\n
\u2022 Financial assets at amortised cost;
\n
\u2022 Financial assets at fair value through OCI with recycling of cumulative gains and losses (not relevant to the
\n
Group);
\n
\u2022 Financial assets designated at fair value through OCI with no recycling of cumulative gains and losses upon
\n
derecognition (equity instruments \u2013 not relevant to the Group); and
\n
\u2022 Financial assets at fair value through profit or loss (equity instruments \u2013 not relevant to the Group).
\n
Financial assets at amortised cost (debt instruments)
\n
The Group measures financial assets at amortised cost if both of the following conditions are met:
\n
\u2022 The financial asset is held within a business model with the objective to hold financial assets in order to
\n
collect contractual cash flows; and
\n
\u2022 The contractual terms of the financial asset give rise on specified dates to cash flows that are solely
\n
payments of principal and interest on the principal amount outstanding.
\n
Financial assets at amortised cost are subsequently measured using the effective interest rate (EIR) method and
\n
are subject to impairment. Gains and losses are recognised in profit or loss when the asset is derecognised,
\n
modified or impaired.
\n
\n\n
\n\n\n
\n\n
\n
\n
Impairment
\n
The Group recognises an allowance for ECLs for all debt instruments not held at fair value through profit or loss.
\n
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all
\n
the cash flows that the Group expects to receive, discounted at an approximation of the original EIR. ECLs are
\n
recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk
\n
since initial recognition, ECLs are provided for credit losses that result from default events that are possible within
\n
the next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in
\n
credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of
\n
the exposure, irrespective of the timing of the default (a lifetime ECL).
\n
For receivables due in less than 12 months, the Group recognises a loss allowance based on the financial asset\u2019s
\n
lifetime ECL at each reporting date.
\n
Given the nature of financial assets held by the Group, it considers a financial asset to be in default when internal
\n
or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full
\n
before taking into account any credit enhancements held by the Group. A financial asset is written off when there
\n
is no reasonable expectation of recovering the contractual cash flows.
\n
At each reporting date, the Group assesses whether financial assets carried at amortised cost are credit impaired.
\n
A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated
\n
future cash flows of the financial asset have occurred.
\n
\n\n
\n
\n\n
\n\n\n
\n\n
\n
(k) Financial Liabilities
\n
(i) Initial recognition and measurement
\n
Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans
\n
and borrowings (amortised cost) or payables.
\n
All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables,
\n
net of directly attributable transaction costs.
\n
The Group\u2019s financial liabilities include trade and other payables and financial liabilities at fair value through profit
\n
or loss.
\n
(ii) Subsequent measurement
\n
The measurement of financial liabilities depends on their classification, as described below:
\n
Amortised cost liabilities
\n
This is the category most relevant to the Group. After initial recognition, amortised cost liabilities are subsequently
\n
measured at amortised cost using the EIR method. Gains and losses are then recognised in profit or loss when the
\n
liabilities are derecognised as well as through the EIR amortisation process.
\n
Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that
\n
are an integral part of the EIR. The EIR amortisation is included as finance costs in the statement of profit or loss.
\n
\n
Financial liabilities at fair value through profit or loss
\n
This is the category least relevant to the Group. Financial liabilities at fair value through profit or loss include
\n
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value
\n
through profit or loss.
\n
Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near
\n
term.
\n
Financial liabilities at fair value through profit or loss
\n
Gains or losses on liabilities held for trading are recognised in the statement of profit or loss.
\n
Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the
\n
initial date of recognition, and only if the criteria in AASB 9 Financial Instruments are satisfied.
\n
\n\n
\n
\n\n
\n\n\n
\n\n
\n
\n
(iii) Derecognition
\n
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.
\n
When an existing financial liability is replaced by another on substantially different terms, or the terms of an
\n
existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the
\n
original liability and the recognition of a new liability. The difference in the respective carrying amounts is
\n
recognised in the statement of profit or loss.
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag293": {
"value": "\n(f) Financial Assets
\n(i) Initial recognition and measurement
\nFinancial assets are classified, at initial recognition, as subsequently measured at amortised cost, fair value through
\nother comprehensive income (OCI), and fair value through profit or loss.
\nThe classification of financial assets at initial recognition depends on the financial asset\u2019s contractual cash flow
\ncharacteristics and the Group\u2019s business model for managing them. The Group initially measures a financial asset
\nat its fair value plus, in the case of a financial asset not at fair value through profit or loss, less transaction costs.
\n(ii) Subsequent measurement
\nFor purposes of subsequent measurement, financial assets are classified in four categories:
\n\u2022 Financial assets at amortised cost;
\n\u2022 Financial assets at fair value through OCI with recycling of cumulative gains and losses (not relevant to the
\nGroup);
\n\u2022 Financial assets designated at fair value through OCI with no recycling of cumulative gains and losses upon
\nderecognition (equity instruments \u2013 not relevant to the Group); and
\n\u2022 Financial assets at fair value through profit or loss (equity instruments \u2013 not relevant to the Group).
\nFinancial assets at amortised cost (debt instruments)
\nThe Group measures financial assets at amortised cost if both of the following conditions are met:
\n\u2022 The financial asset is held within a business model with the objective to hold financial assets in order to
\ncollect contractual cash flows; and
\n\u2022 The contractual terms of the financial asset give rise on specified dates to cash flows that are solely
\npayments of principal and interest on the principal amount outstanding.
\nFinancial assets at amortised cost are subsequently measured using the effective interest rate (EIR) method and
\nare subject to impairment. Gains and losses are recognised in profit or loss when the asset is derecognised,
\nmodified or impaired.
\n
\n\n\n
\n\n
Impairment
\n
The Group recognises an allowance for ECLs for all debt instruments not held at fair value through profit or loss.
\n
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all
\n
the cash flows that the Group expects to receive, discounted at an approximation of the original EIR. ECLs are
\n
recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk
\n
since initial recognition, ECLs are provided for credit losses that result from default events that are possible within
\n
the next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in
\n
credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of
\n
the exposure, irrespective of the timing of the default (a lifetime ECL).
\n
For receivables due in less than 12 months, the Group recognises a loss allowance based on the financial asset\u2019s
\n
lifetime ECL at each reporting date.
\n
Given the nature of financial assets held by the Group, it considers a financial asset to be in default when internal
\n
or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full
\n
before taking into account any credit enhancements held by the Group. A financial asset is written off when there
\n
is no reasonable expectation of recovering the contractual cash flows.
\n
At each reporting date, the Group assesses whether financial assets carried at amortised cost are credit impaired.
\n
A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated
\n
future cash flows of the financial asset have occurred.
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag297": {
"value": "\nImpairment
\nThe Group recognises an allowance for ECLs for all debt instruments not held at fair value through profit or loss.
\nECLs are based on the difference between the contractual cash flows due in accordance with the contract and all
\nthe cash flows that the Group expects to receive, discounted at an approximation of the original EIR. ECLs are
\nrecognised in two stages. For credit exposures for which there has not been a significant increase in credit risk
\nsince initial recognition, ECLs are provided for credit losses that result from default events that are possible within
\nthe next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in
\ncredit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of
\nthe exposure, irrespective of the timing of the default (a lifetime ECL).
\nFor receivables due in less than 12 months, the Group recognises a loss allowance based on the financial asset\u2019s
\nlifetime ECL at each reporting date.
\nGiven the nature of financial assets held by the Group, it considers a financial asset to be in default when internal
\nor external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full
\nbefore taking into account any credit enhancements held by the Group. A financial asset is written off when there
\nis no reasonable expectation of recovering the contractual cash flows.
\nAt each reporting date, the Group assesses whether financial assets carried at amortised cost are credit impaired.
\nA financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated
\nfuture cash flows of the financial asset have occurred.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag298": {
"value": "\n
\n(g) Property, Plant and Equipment
\n(i) Recognition and measurement
\nProperty, plant and equipment is stated at historical cost less accumulated depreciation and any accumulated
\nimpairment losses. Such cost includes the cost of replacing parts that are eligible for capitalisation when the cost
\nof replacing the parts is incurred. Similarly, when each major inspection is performed, its cost is recognised in the
\ncarrying amount of the property, plant and equipment as a replacement only if it is eligible for capitalisation. All
\nother repairs and maintenance are recognised in the Statement of Profit or Loss and other Comprehensive Income
\nas incurred.
\n\n
(ii) Depreciation
\n
Depreciation is provided on a straight-line basis on all property, plant and equipment.
\n
\n
2026
\n
2025
\n
Major depreciation periods (per annum) are:
\n
\n
\n
Plant and equipment:
\n
22% - 40%
\n
22% - 40%
\n
The assets\u2019 residual values, useful lives and amortisation methods are reviewed, and adjusted if appropriate, at
\n
each financial year end.
\n
\n\n
(iii) Derecognition
\nAn item of property, plant and equipment is derecognised upon disposal or when no further future economic
\nbenefits are expected from its use or disposal. Impairment of property, plant and equipment are discussed in note
\n1(s).
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag299": {
"value": "\n(ii) Depreciation
\nDepreciation is provided on a straight-line basis on all property, plant and equipment.
\n
\n2026
\n2025
\nMajor depreciation periods (per annum) are:
\n
\n
\nPlant and equipment:
\n22% - 40%
\n22% - 40%
\nThe assets\u2019 residual values, useful lives and amortisation methods are reviewed, and adjusted if appropriate, at
\neach financial year end.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForDepreciationExpenseExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag300": {
"value": "\n(h) Exploration and Evaluation Expenditure
\nExpenditure on exploration and evaluation is accounted for in accordance with the \u2018area of interest\u2019 method.
\nExploration and evaluation expenditure encompasses expenditures incurred by the Group in connection with the
\nexploration for and evaluation of mineral resources before the technical feasibility and commercial viability of
\nextracting a mineral resource are demonstrable.
\nFor each area of interest, expenditure incurred in the acquisition of rights to explore is capitalised, classified as
\ntangible or intangible, and recognised as an exploration and evaluation asset. Exploration and evaluation assets
\nare measured at cost at recognition and are recorded as an asset if:
\n(i) the rights to tenure of the area of interest are current; and
\n(ii) at least one of the following conditions is also met:
\n\u2022 the exploration and evaluation expenditures are expected to be recouped through successful
\ndevelopment and exploitation of the area of interest, or alternatively, by its sale; and
\n\u2022 exploration and evaluation activities in the area of interest have not at the reporting date reached a stage
\nwhich permits a reasonable assessment of the existence or otherwise of economically recoverable
\nreserves, and active and significant operations in, or in relation to, the area of interest are continuing.
\nExploration and evaluation expenditure incurred by the Group subsequent to acquisition of the rights to explore
\nis expensed as incurred, up to costs associated with the preparation of a feasibility study.
\n
\n\n\nImpairment
\nCapitalised exploration costs are reviewed each reporting date to establish whether an indication of impairment
\nexists. If any such indication exists, the recoverable amount of the capitalised exploration costs is estimated to
\ndetermine the extent of the impairment loss (if any). Where an impairment loss subsequently reverses, the
\ncarrying amount of the asset is increased to the revised estimate of its recoverable amount, but only to the extent
\nthat the increased carrying amount does not exceed the carrying amount that would have been determined had
\nno impairment loss been recognised for the asset in previous years.
\nWhere a decision is made to proceed with development, accumulated expenditure is tested for impairment and
\ntransferred to development properties, and then amortised over the life of the reserves associated with the area
\nof interest once mining operations have commenced. Recoverability of the carrying amount of the exploration
\nand evaluation assets is dependent on successful development and commercial exploitation, or alternatively, sale
\nof the respective areas of interest.
\nGrant funding receivable
\nWhere funds are received or receivable from partners regarding monetary contributions for project identification,
\nvalidation or exploration, the funds received are allocated in the financial statements against the corresponding
\nexpense or exploration asset.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag302": {
"value": "\n(i) Payables
\nLiabilities are recognised for amounts to be paid in the future for goods and services received. Trade accounts
\npayable are normally settled within 30 days. Payables are carried at amortised cost.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag303": {
"value": "\n(j) Provisions
\nProvisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past
\nevent, it is probable that an outflow of resources embodying economic benefits will be required to settle the
\nobligation and a reliable estimate can be made of the amount of the obligation.
\nProvisions are measured at the present value of management\u2019s best estimate of the expenditure required to settle
\nthe present obligation at the reporting date. If the effect of the time value of money is material, provisions are
\ndiscounted using a current pre-tax rate that reflects, when appropriate, the risks specific to the liability. When
\ndiscounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag305": {
"value": "\nFinancial liabilities at fair value through profit or loss
\nThis is the category least relevant to the Group. Financial liabilities at fair value through profit or loss include
\nfinancial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value
\nthrough profit or loss.
\nFinancial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near
\nterm.
\nFinancial liabilities at fair value through profit or loss
\nGains or losses on liabilities held for trading are recognised in the statement of profit or loss.
\nFinancial liabilities designated upon initial recognition at fair value through profit or loss are designated at the
\ninitial date of recognition, and only if the criteria in AASB 9 Financial Instruments are satisfied.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag307": {
"value": "\n
\n\n
(iii) Derecognition
\n
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.
\n
When an existing financial liability is replaced by another on substantially different terms, or the terms of an
\n
existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the
\n
original liability and the recognition of a new liability. The difference in the respective carrying amounts is
\n
recognised in the statement of profit or loss.
\n
\n\n
\n\n\n
\n(k) Financial Liabilities
\n(i) Initial recognition and measurement
\nFinancial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans
\nand borrowings (amortised cost) or payables.
\nAll financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables,
\nnet of directly attributable transaction costs.
\nThe Group\u2019s financial liabilities include trade and other payables and financial liabilities at fair value through profit
\nor loss.
\n(ii) Subsequent measurement
\nThe measurement of financial liabilities depends on their classification, as described below:
\nAmortised cost liabilities
\nThis is the category most relevant to the Group. After initial recognition, amortised cost liabilities are subsequently
\nmeasured at amortised cost using the EIR method. Gains and losses are then recognised in profit or loss when the
\nliabilities are derecognised as well as through the EIR amortisation process.
\nAmortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that
\nare an integral part of the EIR. The EIR amortisation is included as finance costs in the statement of profit or loss.
\n\n
Financial liabilities at fair value through profit or loss
\n
This is the category least relevant to the Group. Financial liabilities at fair value through profit or loss include
\n
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value
\n
through profit or loss.
\n
Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near
\n
term.
\n
Financial liabilities at fair value through profit or loss
\n
Gains or losses on liabilities held for trading are recognised in the statement of profit or loss.
\n
Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the
\n
initial date of recognition, and only if the criteria in AASB 9 Financial Instruments are satisfied.
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag308": {
"value": "\n(iii) Derecognition
\nA financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.
\nWhen an existing financial liability is replaced by another on substantially different terms, or the terms of an
\nexisting liability are substantially modified, such an exchange or modification is treated as the derecognition of the
\noriginal liability and the recognition of a new liability. The difference in the respective carrying amounts is
\nrecognised in the statement of profit or loss.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag309": {
"value": "\n(l) Revenue Recognition
\nRevenue is recognised when control of goods is transferred to the customer at an amount that reflects the
\nconsideration to which the Group expects to be entitled to in exchange for those goods.
\nInterest revenue is recognised as it accrues, taking into account the effective yield on the financial asset.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag310": {
"value": "\n
\n(m) Income Tax
\nThe income tax expense for the period is the tax payable on the current period\u2019s taxable income based on the
\nnational income tax rate for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable
\nto temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial
\nstatements, and to unused tax losses.
\n\n
Deferred tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when
\n
the assets are recovered or liabilities are settled, based on those tax rates which are enacted or substantively
\n
enacted at balance date for each jurisdiction. The relevant tax rates are applied to the cumulative amounts of
\n
deductible and taxable temporary differences to measure the deferred tax asset or liability. An exception is made
\n
for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax asset
\n
or liability is recognised in relation to these temporary differences if they arose on goodwill or in a transaction,
\n
other than a business combination, that at the time of the transaction did not affect either accounting profit or
\n
taxable profit or loss.
\n
Deferred tax liabilities and assets are not recognised for temporary differences between the carrying amount and
\n
tax bases of investments in controlled entities where the Company is able to control the timing of the reversal of
\n
the temporary differences and it is probable that the differences will not reverse in the foreseeable future.
\n
Deferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable
\n
that future taxable amounts will be available to utilise those temporary differences and losses.
\n
The carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent
\n
that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income
\n
tax asset to be utilised.
\n
Unrecognised deferred income tax assets are reassessed at each balance date and are recognised to the extent
\n
that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
\n
Current and deferred tax balances attributable to amounts recognised directly in equity are also recognised
\n
directly in equity.
\n
Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current
\n
tax assets against tax liabilities and the deferred tax liabilities relate to the same taxable entity and the same
\n
taxation authority.
\n
\n\n
(n) Tax consolidation
\nGreenX Metals Limited and its wholly-owned Australian subsidiaries have formed an income tax consolidated
\ngroup under the tax consolidation regime. Each entity in the tax consolidated group recognises its own current
\nand deferred tax liabilities, except for any deferred tax assets resulting from unused tax losses and tax credits,
\nwhich are immediately assumed by the Company (which is the head entity in the tax consolidated group). The
\ncurrent tax liability of each group entity is then subsequently assumed by the Company. The tax consolidated
\ngroup has entered a tax sharing agreement whereby each company in the Group contributes to the income tax
\npayable in proportion to their contribution to the net profit before tax of the tax consolidated group.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag311": {
"value": "\nDeferred tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when
\nthe assets are recovered or liabilities are settled, based on those tax rates which are enacted or substantively
\nenacted at balance date for each jurisdiction. The relevant tax rates are applied to the cumulative amounts of
\ndeductible and taxable temporary differences to measure the deferred tax asset or liability. An exception is made
\nfor certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax asset
\nor liability is recognised in relation to these temporary differences if they arose on goodwill or in a transaction,
\nother than a business combination, that at the time of the transaction did not affect either accounting profit or
\ntaxable profit or loss.
\nDeferred tax liabilities and assets are not recognised for temporary differences between the carrying amount and
\ntax bases of investments in controlled entities where the Company is able to control the timing of the reversal of
\nthe temporary differences and it is probable that the differences will not reverse in the foreseeable future.
\nDeferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable
\nthat future taxable amounts will be available to utilise those temporary differences and losses.
\nThe carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent
\nthat it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income
\ntax asset to be utilised.
\nUnrecognised deferred income tax assets are reassessed at each balance date and are recognised to the extent
\nthat it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
\nCurrent and deferred tax balances attributable to amounts recognised directly in equity are also recognised
\ndirectly in equity.
\nDeferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current
\ntax assets against tax liabilities and the deferred tax liabilities relate to the same taxable entity and the same
\ntaxation authority.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag312": {
"value": "\n(o) Employee Entitlements
\nProvision is made for the Group\u2019s liability for employee benefits arising from services rendered by employees to
\nbalance date. Employee benefits that are expected to be settled within 12 months have been measured at the
\namounts expected to be paid when the liability is settled, plus related on-costs. Employee benefits payable later
\nthan 12 months have been measured using the projected unit credit valuation method.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag313": {
"value": "\n(p) Earnings per Share
\nBasic earnings per share (EPS) is calculated by dividing the net profit attributable to members of the Company for
\nthe reporting period, after excluding any costs of servicing equity, by the weighted average number of Ordinary
\nShares of the Company, adjusted for any bonus issue.
\n
\n\n\nDiluted EPS is calculated by dividing the basic EPS earnings, adjusted by the after tax effect of financing costs
\nassociated with dilutive potential Ordinary Shares and the effect on revenues and expenses of conversion to
\nOrdinary Shares associated with dilutive potential Ordinary Shares, by the weighted average number of Ordinary
\nShares and dilutive Ordinary Shares adjusted for any bonus issue.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag315": {
"value": "\n(q) Goods and Services Tax (GST)
\nRevenues, expenses and assets are recognised net of the amount of GST, except where the amount of GST incurred
\nis not recoverable from the Australian Tax Office. In these circumstances the GST is recognised as part of the cost
\nof acquisition of the asset or as part of the expense. Receivables and payables in the statement of financial position
\nare shown inclusive of GST.
\nCash flows are presented in the cash flow statement on a gross basis, except for the GST component of investing
\nand financing activities, which are disclosed as operating cash flows.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag316": {
"value": "\n(s) Impairment of non-current Assets
\nThe Group assesses at each reporting date whether there is an indication that a non-current asset may be
\nimpaired. If any such indication exists, or when annual impairment testing for an asset is required, the Group
\nmakes an estimate of the asset's recoverable amount. An asset's recoverable amount is the higher of its fair value
\nless costs of disposal and its value in use and is determined for an individual asset, unless the asset does not
\ngenerate cash inflows that are largely independent of those from other assets or groups of assets and the asset's
\nvalue in use cannot be estimated to be close to its fair value. In such cases the asset is tested for impairment as
\npart of the cash-generating unit to which it belongs. When the carrying amount of an asset or cash-generating
\nunit exceeds its recoverable amount, the asset or cash-generating unit is considered impaired and is written down
\nto its recoverable amount.
\nIn assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax
\ndiscount rate that reflects current market assessments of the time value of money and the risks specific to the
\nasset.
\nAn assessment is also made at each reporting date as to whether there is any indication that previously recognised
\nimpairment losses may no longer exist or may have decreased. If such indication exists, the recoverable amount is
\nestimated. A previously recognised impairment loss is reversed only if there has been a change in the estimates
\nused to determine the asset's recoverable amount since the last impairment loss was recognised. If that is the case
\nthe carrying amount of the asset is increased to its recoverable amount.
\nThat increased amount cannot exceed the carrying amount that would have been determined, net of
\ndepreciation, had no impairment loss been recognised for the asset in prior years. Such reversal is recognised in
\nprofit or loss. After such a reversal the depreciation charge is adjusted in future periods to allocate the asset's
\nrevised carrying amount, less any residual value, on a systematic basis over its remaining useful life.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag317": {
"value": "\n(t) Fair Value Estimation
\nThe fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for
\ndisclosure purposes.
\nThe fair value of financial instruments traded in active markets is based on quoted market prices at the reporting
\ndate. The quoted market price used for financial assets held by the Group is the current bid price; the appropriate
\nquoted market price for financial liabilities is the current ask price.
\nThe net carrying value of trade receivables and payables are short term in nature and approximate their fair values.
\nThe fair value of financial liabilities for disclosure purposes is estimated by discounting the future contractual cash
\nflows at the current market interest rate that is available to the Group for similar financial instruments.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag318": {
"value": "\n(u) Issued and Unissued Capital
\nOrdinary Shares are classified as equity. Issued and paid up capital is recognised at the fair value of the
\nconsideration received by the Company. Incremental costs directly attributable to the issue of new shares or
\noptions are shown in equity as a deduction, net of tax, from the proceeds.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag319": {
"value": "\n
\n(v) Foreign Currencies
\n\n
(i) Functional and presentation currency
\n
The functional currency of each of the Group's entities is measured using the currency of the primary economic
\n
environment in which that entity operates. The consolidated financial statements are presented in Australian
\n
dollars which is the Company's functional and presentation currency.
\n
\n\n
\n\n\nTransactions and balances
\nForeign currency transactions are translated into functional currency using the exchange rates prevailing at the
\ndate of the transaction. Foreign currency monetary items are translated at the year-end exchange rate. Non-
\nmonetary items measured at historical cost continue to be carried at the exchange rate at the date of the
\ntransaction.
\nExchange differences arising on the translation of monetary items are recognised in the Statement Profit or Loss
\nand other Comprehensive Income.
\nExchange differences arising on the translation of non-monetary items are recognised directly in equity to the
\nextent that the gain or loss is directly recognised in equity, otherwise the exchange difference is recognised in the
\nother Comprehensive Income.
\n(ii) Group companies
\nThe financial results and position of foreign operations whose functional currency is different from the Group's
\npresentation currency are translated as follows:
\n\u2022 assets and liabilities are translated at year-end exchange rates prevailing at that reporting date;
\n\u2022 income and expenses are translated at average exchange rates for the period; and
\n\u2022 items of equity are translated at the historical exchange rates prevailing at the date of the transaction.
\nExchange differences arising on translation of foreign operations are transferred to the group's foreign currency
\ntranslation reserve in the Statement of Financial Position. The accumulated difference is reclassified in the
\nStatement of Profit or Loss and other Comprehensive Income in the period in which the operation is disposed.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag320": {
"value": "\n(i) Functional and presentation currency
\nThe functional currency of each of the Group's entities is measured using the currency of the primary economic
\nenvironment in which that entity operates. The consolidated financial statements are presented in Australian
\ndollars which is the Company's functional and presentation currency.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag322": {
"value": "\n(w) Share-Based Payments
\nEquity-settled share-based payments are provided to officers, employees, consultants and other advisors. These
\nshare-based payments are measured at the fair value of the equity instrument at the grant date. Fair value is
\ndetermined using the Binomial option pricing model. Further details on how the fair value of equity-settled share-
\nbased payments has been determined can be found in Note 19.
\nThe fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on
\nthe Company's estimate of equity instruments that will eventually vest. At each reporting date, the Company
\nrevises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original
\nestimates, if any, is recognised in profit or loss over the remaining vesting period, with a corresponding adjustment
\nto the option premium reserve.
\nEquity-settled share-based payments may also be provided as consideration for the acquisition of assets. Where
\nOrdinary Shares are issued, the transaction is recorded at fair value based on the quoted price of the Ordinary
\nShares at the grant date. The acquisition is then recorded as an asset or expensed in accordance with accounting
\nstandards. Unvested incentive securities that lapse when non-market conditions are not met are reversed from
\nthe share-based payment reserve to the Statement of Profit or Loss.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag323": {
"value": "\n(y) Use and Revision of Accounting Estimates, Judgements and Assumptions
\nThe preparation of the financial report requires management to make judgements, estimates and assumptions
\nthat affect the application of accounting policies and the reported amounts of assets, liabilities, income and
\nexpenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed
\non an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is
\nrevised if the revision affects only that period, or in the period of the revision and future periods if the revision
\naffects both current and future periods.
\nIn particular, information about significant areas of estimation uncertainty and critical judgements in applying
\naccounting policies that have the most significant effect on the amount recognised in the financial statements
\nare described in the following notes:
\n\u2022 Share-Based Payments (Note 19) - The Group initially measures the cost of equity-settled transactions with
\nemployees by reference to the fair value of the equity instrument at the date at which they are granted.
\nEstimating fair value for share-based payment transactions requires the determination of the most
\nappropriate valuation model. This estimate also requires the determination of the most appropriate inputs
\nto the valuation model including the expected life of the share option, volatility and dividend yield. The
\nassumption and models used for estimating the fair value for share-based payment transactions are
\ndisclosed in Note 19.
\n
\n\n\n\u2022 Functional currency of foreign operations (Note 22 (g)) - determination of the functional currency of foreign
\nsubsidiaries requires judgement regarding the primary currency of labour, material and exploration spend
\nin that subsidiary.
\n\u2022 Exploration and Evaluation Assets (Note 6) \u2013 the Group\u2019s accounting policy for exploration and evaluation
\nassets is set out in Note 1(h). The application of this policy requires management to make certain
\njudgements and estimates as to future events and circumstances, in particular, the assessment of whether
\neconomic quantities of reserves have been found and the point at which exploration and evaluation assets
\nshould be transferred to mine development properties. The determination of an area of interest also
\nrequires judgement.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag325": {
"value": "\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag326": {
"value": "\n2. REVENUE AND OTHER INCOME
\n
\n
\n2026
\n2025
\n
\n
\n$
\n$
\n\n
\n
\n
\n
\n
\n
\n
(a) Revenue
\n
\n
\n
\n
Interest income
\n
\n
308,459
\n
244,867
\n
\n
\n
308,459
\n
244,867
\n
\n
\n
\n
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfRevenueExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag327": {
"value": "\n
\n\n
\n
\n
\n
\n
(a) Revenue
\n
\n
\n
\n
Interest income
\n
\n
308,459
\n
244,867
\n
\n
\n
308,459
\n
244,867
\n
\n
\n
\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfInterestIncomeExpenseExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag328": {
"value": "\n
\n
\n
\n
\n(a) Revenue
\n
\n
\n
\nInterest income
\n
\n308,459
\n244,867
\n
\n
\n308,459
\n244,867
\n
\n
\n
\n
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfInterestIncomeExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag329": {
"value": "\n(b) Other income
\n
\n
\n
\nArbitration finance facility income
\n
\n-
\n251,593
\nRecoupment of arbitration costs
\n
\n1,591,586
\n-
\nOther
\n
\n-
\n27,483
\n
\n
\n1,591,586
\n279,076
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag330": {
"value": "\n
\n3. EXPENSES
\n
\n
\n2026
\n 2025
\n
\nNote
\n$
\n$
\n
\n
\n
\n
\n\n
(a) Employee benefits expense
\n
\n
\n
\n
Salaries and wages
\n
\n
(906,735)
\n
(961,560)
\n
Superannuation expense
\n
\n
(6,720)
\n
(6,440)
\n
Employment expenses
\n
\n
(913,455)
\n
(968,000)
\n
Share-based payment expense
\n
19(a)
\n
(1,373,037)
\n
(136,955)
\n
Employment expenses recorded in exploration and evaluation expenses
\n
\n
(443,589)
\n
(452,077)
\n
Total employment expenses included in profit or loss
\n
\n
(2,730,081)
\n
(1,557,032)
\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfExpensesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag331": {
"value": "\n(a) Employee benefits expense
\n
\n
\n
\nSalaries and wages
\n
\n(906,735)
\n(961,560)
\nSuperannuation expense
\n
\n(6,720)
\n(6,440)
\nEmployment expenses
\n
\n(913,455)
\n(968,000)
\nShare-based payment expense
\n19(a)
\n(1,373,037)
\n(136,955)
\nEmployment expenses recorded in exploration and evaluation expenses
\n
\n(443,589)
\n(452,077)
\nTotal employment expenses included in profit or loss
\n
\n(2,730,081)
\n(1,557,032)
\n
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag332": {
"value": "\n
\n4. INCOME TAX
\n
\n2026
\n2025
\n
\n$
\n$
\n
\n
\n
\n(a) Recognised in the statement of comprehensive income
\n
\n
\nCurrent income tax
\n
\n
\nCurrent income tax benefit in respect of the current year
\n-
\n-
\n\n
Deferred income tax
\n
\n
\n
Relating to origination and reversal of temporary differences
\n
-
\n
-
\n
Income tax expense/(benefit) reported in the statement of Profit or Loss and other
\n
Comprehensive income
\n
-
\n
-
\n
\n
\n
\n
(b) Reconciliation between tax expense and accounting loss before income
\n
tax
\n
\n
\n
Accounting loss before income tax
\n
(12,339,989)
\n
(6,022,365)
\n
\n
\n
\n
At the domestic income tax rate of 30% (2025: 30%)
\n
(3,701,997)
\n
(1,806,709)
\n
Expenditure not allowable for income tax purposes
\n
3,568,250
\n
1,464,151
\n
Income not assessable for income tax purposes
\n
(505,487)
\n
(114,997)
\n
Adjustments in respect of deferred income tax of previous years
\n
(106,844)
\n
(85,919)
\n
Deferred tax assets not brought to account
\n
746,078
\n
543,474
\n
Income tax expense/(benefit) reported in the statement of Profit or Loss and other
\n
Comprehensive income
\n
-
\n
-
\n
(c) Deferred Tax Assets and Liabilities
\n
\n
\n
Deferred income tax at 30 June relates to the following:
\n
\n
\n
\n
\n
\n
Deferred Tax Liabilities
\n
\n
\n
Receivables
\n
15,002
\n
6,521
\n
Deferred tax assets used to offset deferred tax liabilities
\n
(15,002)
\n
(6,521)
\n
\n
-
\n
-
\n
\n
\n
\n
Deferred Tax Assets
\n
\n
\n
Accrued expenditure
\n
77,698
\n
74,232
\n
Right-of-use assets
\n
1,286
\n
(3,520)
\n
Capital allowances
\n
123,200
\n
122,013
\n
Tax losses available to offset against future taxable income
\n
7,309,148
\n
6,624,407
\n
Deferred tax assets used to offset deferred tax liabilities
\n
(15,002)
\n
(6,521)
\n
Deferred tax assets not brought to account
\n
(7,496,330)
\n
(6,810,611)
\n
\n
-
\n
-
\n
The benefit of deferred tax assets not brought to account will only be brought to account if:
\n
\u2022 future assessable income is derived of a nature and of an amount sufficient to enable the benefit to be
\n
realised;
\n
\u2022 the conditions for deductibility imposed by tax legislation continue to be complied with; and
\n
\u2022 no changes in tax legislation adversely affect the Group in realising the benefit.
\n
The Company has not recognised unused carry forward tax losses in Poland of $22,637,060 (2025: $26,228,783) as
\n
the losses are unlikely to be utilised in the future. In Poland, a company's unused carry forward tax loss may
\n
generally be carried forward for 5 consecutive tax years
\n
\n\n
(d) Tax Consolidation
\nThe Company and its wholly-owned Australian resident entities have formed a tax consolidated group and are
\ntherefore taxed as a single entity. The head entity within the tax consolidated group is GreenX Metals Limited.
\n
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag333": {
"value": "\nDeferred income tax
\n
\n
\nRelating to origination and reversal of temporary differences
\n-
\n-
\nIncome tax expense/(benefit) reported in the statement of Profit or Loss and other
\nComprehensive income
\n-
\n-
\n
\n
\n
\n(b) Reconciliation between tax expense and accounting loss before income
\ntax
\n
\n
\nAccounting loss before income tax
\n(12,339,989)
\n(6,022,365)
\n
\n
\n
\nAt the domestic income tax rate of 30% (2025: 30%)
\n(3,701,997)
\n(1,806,709)
\nExpenditure not allowable for income tax purposes
\n3,568,250
\n1,464,151
\nIncome not assessable for income tax purposes
\n(505,487)
\n(114,997)
\nAdjustments in respect of deferred income tax of previous years
\n(106,844)
\n(85,919)
\nDeferred tax assets not brought to account
\n746,078
\n543,474
\nIncome tax expense/(benefit) reported in the statement of Profit or Loss and other
\nComprehensive income
\n-
\n-
\n(c) Deferred Tax Assets and Liabilities
\n
\n
\nDeferred income tax at 30 June relates to the following:
\n
\n
\n
\n
\n
\nDeferred Tax Liabilities
\n
\n
\nReceivables
\n15,002
\n6,521
\nDeferred tax assets used to offset deferred tax liabilities
\n(15,002)
\n(6,521)
\n
\n-
\n-
\n
\n
\n
\nDeferred Tax Assets
\n
\n
\nAccrued expenditure
\n77,698
\n74,232
\nRight-of-use assets
\n1,286
\n(3,520)
\nCapital allowances
\n123,200
\n122,013
\nTax losses available to offset against future taxable income
\n7,309,148
\n6,624,407
\nDeferred tax assets used to offset deferred tax liabilities
\n(15,002)
\n(6,521)
\nDeferred tax assets not brought to account
\n(7,496,330)
\n(6,810,611)
\n
\n-
\n-
\nThe benefit of deferred tax assets not brought to account will only be brought to account if:
\n\u2022 future assessable income is derived of a nature and of an amount sufficient to enable the benefit to be
\nrealised;
\n\u2022 the conditions for deductibility imposed by tax legislation continue to be complied with; and
\n\u2022 no changes in tax legislation adversely affect the Group in realising the benefit.
\nThe Company has not recognised unused carry forward tax losses in Poland of $22,637,060 (2025: $26,228,783) as
\nthe losses are unlikely to be utilised in the future. In Poland, a company's unused carry forward tax loss may
\ngenerally be carried forward for 5 consecutive tax years
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag341": {
"value": "\n5. TRADE AND OTHER RECEIVABLES
\n
\n
\n2026
\n2025
\n
\n
\n$
\n$
\n
\n
\n
\n
\nTrade receivables
\n
\n215,161
\n184,794
\nInterest receivable
\n
\n50,007
\n21,737
\nDeposits/prepayments
\n
\n104,999
\n102,567
\nGST and other receivables
\n
\n175,361
\n250,488
\n
\n
\n545,528
\n559,586
\nNote:
\n1
\n As at 30 June 2026 (2025: nil), no amounts are past due or impaired.
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag334": {
"value": "\n6. EXPLORATION AND EVALUATION ASSETS
\n
\n
\nTannenberg
\nProject
\n$
\nEleonore North
\nGold Project
\n$
\nArctic Rift
\nCopper Project
\n$
\nTotal
\n$
\nCarrying amount at 1 July 2025
\n990,279
\n1,902,906
\n7,770,000
\n10,663,185
\nTannenberg acquisition consideration: Issue
\nof 3,487,147 Ordinary Shares (Notes 7 and 12)
\n3,000,000
\n-
\n-
\n3,000,000
\nELN deferred consideration: Issue of 1,141,409
\nOrdinary Shares
\n1
\n
\n-
\n1,000,000
\n-
\n1,000,000
\nTannenberg expenditure
\n685,716
\n-
\n-
\n685,716
\nExploration costs funded by project BHP
\nXplor program
\n2
\n
\n(533,161)
\n-
\n-
\n(533,161)
\nReversal of unvested Performance Rights
\n(Note 13)
\n-
\n-
\n(3,355,000)
\n4
\n
\n(3,355,000)
\nExploration and evaluation impairedf
\n3
\n
\n-
\n-
\n(4,415,000)
\n(4,415,000)
\nCarrying amount at 30 June 2026
\n4,142,834
\n2,902,906
\n-
\n7,045,740
\n
\n
\n
\n
\n
\nCarrying amount at 1 July 2024
\n-
\n1,602,906
\n7,770,000
\n9,372,906
\nELN acquisition consideration: Issue of
\n382,636 Ordinary Shares to GEX (Note 12)
\n-
\n300,000
\n-
\n300,000
\nTannenberg expenditure
\n862,053
\n-
\n-
\n862,053
\nTannenberg acquisition consideration: Issue
\nof 500,000 Ordinary Shares (Note 12)
\n405,000
\n-
\n-
\n405,000
\nExploration costs funded by project BHP
\nXplor program
\n2
\n
\n(276,774)
\n-
\n-
\n(276,774)
\nCarrying amount at 30 June 2025
\n990,279
\n1,902,906
\n7,770,000
\n10,663,185
\nNote:
\n1
\n In July 2024, GreenX entered into a revised agreement to acquire 100% of the Eleonore North project. As part of the revised agreement, a deferred
\npayment of A$1,000,000 in cash or GreenX shares was required to be made for GreenX to retain its 100% interest in ELN project. On 24 November
\n2025, GreenX announced that it would retain its interest in ELN and GreenX issued 1,141,409 ordinary shares (subject to 12 months escrow) to satisfy
\nthe deferred payment.
\n2
\n Relates to amounts funded by the grant received from BHP in respect of the BHP Xplor program. The Company received a total of $809,935
\n(US$500,000)(which includes a foreign exchange adjustment of $19,864 recorded in the year (2025: nil), in funding pursuant to the Xplor program,
\nwith $533,161 (2025: $276,774) of the grant spent during the period.
\n3
\nThe ultimate recoupment of costs carried forward for exploration and evaluation is dependent on the successful development and commercial
\nexploitation or sale of the respective areas of interest. An impairment expense was recognised during the period $4,415,000 (2025: nil) in relation to
\nareas of interest where no future exploration and evaluation activities are expected.
\n4
\nDuring the year, it was determined that 11,000,000 performance rights that that relate to ARC and expire on 8 October 2026 will lapse unvested on
\nthe relevant expiry date as the milestones have been determined to be unachievable prior to their expiry date (Notes 13 and 19(b)).
\n
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag342": {
"value": "\n7. ASSET ACQUISITION
\nOn 2 August 2024, GreenX entered into JVA with Group 11 through which GreenX could earn a 90% interest in
\nTannenberg. As a result of the progress made on the Project during the period, GreenX elected to acquire 90% of
\nthe fully diluted share capital of Group 11. On electing to acquire 90% of Group 11, GreenX was required to pay
\nA$3,000,000 to the vendors in GreenX shares which resulted in the issue of 3,487,147 Ordinary Shares (refer to
\nNotes 6 and 12).
\nIn line with relevant accounting standards, the Company has treated the acquisition of Group 11 as an asset
\nacquisition and a share-based payment transaction under AASB 2 Share Based Payments. At the time of acquiring
\n90% of Group 11, Group 11 did not hold any material assets or liabilities, other than the Tannenberg exploration
\nlicences.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag343": {
"value": "\n
\n\n
\n
8. PROPERTY, PLANT AND EQUIPMENT
\n
\n
\n
Plant and
\n
equipment
\n
Right-of-use assets
\n
Total
\n
\n
$
\n
$
\n
$
\n
Carrying amount at 1 July 2025
\n
6,212
\n
11,733
\n
17,945
\n
Additions
\n
18,118
\n
904,897
\n
923,015
\n
Depreciation and amortisation
\n
(8,706)
\n
(290,163)
\n
(298,869)
\n
Carrying amount at 30 June 2026
\n
15,624
\n
626,467
\n
642,091
\n
- at cost
\n
830,585
\n
904,897
\n
1,735,482
\n
- accumulated depreciation, amortisation and impairment
\n
(814,961)
\n
(278,430)
\n
(1,093,391)
\n
\n
\n
\n
\n
Carrying amount at 1 July 2024
\n
8,349
\n
274,112
\n
282,461
\n
Additions
\n
4,020
\n
-
\n
4,020
\n
Depreciation and amortisation
\n
(6,157)
\n
(262,379)
\n
(268,536)
\n
Carrying amount at 30 June 2025
\n
6,212
\n
11,733
\n
17,945
\n
- at cost
\n
812,467
\n
1,487,519
\n
2,302,032
\n
- accumulated depreciation, amortisation and impairment
\n
(806,255)
\n
(1,475,786)
\n
(2,284,087)
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag344": {
"value": "\n
\n8. PROPERTY, PLANT AND EQUIPMENT
\n\n
\n
Plant and
\n
equipment
\n
Right-of-use assets
\n
Total
\n
\n
$
\n
$
\n
$
\n
Carrying amount at 1 July 2025
\n
6,212
\n
11,733
\n
17,945
\n
Additions
\n
18,118
\n
904,897
\n
923,015
\n
Depreciation and amortisation
\n
(8,706)
\n
(290,163)
\n
(298,869)
\n
Carrying amount at 30 June 2026
\n
15,624
\n
626,467
\n
642,091
\n
- at cost
\n
830,585
\n
904,897
\n
1,735,482
\n
- accumulated depreciation, amortisation and impairment
\n
(814,961)
\n
(278,430)
\n
(1,093,391)
\n
\n
\n
\n
\n
Carrying amount at 1 July 2024
\n
8,349
\n
274,112
\n
282,461
\n
Additions
\n
4,020
\n
-
\n
4,020
\n
Depreciation and amortisation
\n
(6,157)
\n
(262,379)
\n
(268,536)
\n
Carrying amount at 30 June 2025
\n
6,212
\n
11,733
\n
17,945
\n
- at cost
\n
812,467
\n
1,487,519
\n
2,302,032
\n
- accumulated depreciation, amortisation and impairment
\n
(806,255)
\n
(1,475,786)
\n
(2,284,087)
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag345": {
"value": "\n
\nPlant and
\nequipment
\nRight-of-use assets
\nTotal
\n
\n$
\n$
\n$
\nCarrying amount at 1 July 2025
\n6,212
\n11,733
\n17,945
\nAdditions
\n18,118
\n904,897
\n923,015
\nDepreciation and amortisation
\n(8,706)
\n(290,163)
\n(298,869)
\nCarrying amount at 30 June 2026
\n15,624
\n626,467
\n642,091
\n - at cost
\n830,585
\n904,897
\n1,735,482
\n - accumulated depreciation, amortisation and impairment
\n(814,961)
\n(278,430)
\n(1,093,391)
\n
\n
\n
\n
\nCarrying amount at 1 July 2024
\n8,349
\n274,112
\n282,461
\nAdditions
\n4,020
\n-
\n4,020
\nDepreciation and amortisation
\n(6,157)
\n(262,379)
\n(268,536)
\nCarrying amount at 30 June 2025
\n6,212
\n11,733
\n17,945
\n - at cost
\n812,467
\n1,487,519
\n2,302,032
\n - accumulated depreciation, amortisation and impairment
\n(806,255)
\n(1,475,786)
\n(2,284,087)
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag346": {
"value": "\n9. TRADE AND OTHER PAYABLES
\n
\n
\n2026
\n2025
\n
\n
\n$
\n$
\n
\n
\n
\n
\nTrade and other payables
\n
\n1,090,093
\n745,236
\nArbitration expenses payable
\n
\n1,228,519
\n1,602,467
\n
\n
\n2,318,612
\n2,347,703
\nNotes:
\n1
\n Trade payables are non-interest bearing and are normally settled on 30-day terms.
\n2
\n Other payables are non-interest bearing and have an average term of six months.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag347": {
"value": "\n
\n\n
\n
\n
\n
\n
10. OTHER FINANCIAL LIABILITIES
\n
\n
Note
\n
2026
\n
2025
\n
\n
\n
$
\n
$
\n
\n
\n
\n
\n
(a) Current Liabilities:
\n
\n
\n
\n
Grant received, E&E expenditures not yet incurred
\n
1
\n
\n
6
\n
-
\n
533,161
\n
Lease Liability
\n
2
\n
\n
\n
263,608
\n
-
\n
\n
\n
263,608
\n
533,161
\n
\n
\n
\n
\n
(b) Non-Current Liabilities:
\n
\n
\n
\n
Lease Liability
\n
2
\n
\n
\n
367,148
\n
-
\n
\n
\n
367,148
\n
-
\n
Note:
\n
1
\n
Please refer to Note 6 for further discussion.
\n
\n
2
\n
During the period, the Company entered into an office lease which commenced on 29 July 2025 with the principal rent amount of \u00a3164,540
\n
($337,420) per annum commencing from the start date of the lease, expiring on 30 June 2028. Refer to Note 8 for the carrying amount of the
\n
right-of-use asset. The following are amounts recognised in the Statement of Profit and Loss: (i) amortisation expense of right-of-use asset
\n
$290,163 (2025: $262,380); (ii) interest expense on lease liabilities of $79,228 (2025: $13,285); and (iii) rent expense of $216,844 (2025: $95,950).
\n
\n\n
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfLeasesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag348": {
"value": "\n
\n\n
\n
\n
10. OTHER FINANCIAL LIABILITIES
\n
\n
Note
\n
2026
\n
2025
\n
\n
\n
$
\n
$
\n
\n
\n
\n
\n
(a) Current Liabilities:
\n
\n
\n
\n
Grant received, E&E expenditures not yet incurred
\n
1
\n
\n
6
\n
-
\n
533,161
\n
Lease Liability
\n
2
\n
\n
\n
263,608
\n
-
\n
\n
\n
263,608
\n
533,161
\n
\n
\n
\n
\n
(b) Non-Current Liabilities:
\n
\n
\n
\n
Lease Liability
\n
2
\n
\n
\n
367,148
\n
-
\n
\n
\n
367,148
\n
-
\n
Note:
\n
1
\n
Please refer to Note 6 for further discussion.
\n
\n
2
\n
During the period, the Company entered into an office lease which commenced on 29 July 2025 with the principal rent amount of \u00a3164,540
\n
($337,420) per annum commencing from the start date of the lease, expiring on 30 June 2028. Refer to Note 8 for the carrying amount of the
\n
right-of-use asset. The following are amounts recognised in the Statement of Profit and Loss: (i) amortisation expense of right-of-use asset
\n
$290,163 (2025: $262,380); (ii) interest expense on lease liabilities of $79,228 (2025: $13,285); and (iii) rent expense of $216,844 (2025: $95,950).
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag349": {
"value": "\n
\n\n
10. OTHER FINANCIAL LIABILITIES
\n
\n
Note
\n
2026
\n
2025
\n
\n
\n
$
\n
$
\n
\n
\n
\n
\n
(a) Current Liabilities:
\n
\n
\n
\n
Grant received, E&E expenditures not yet incurred
\n
1
\n
\n
6
\n
-
\n
533,161
\n
Lease Liability
\n
2
\n
\n
\n
263,608
\n
-
\n
\n
\n
263,608
\n
533,161
\n
\n
\n
\n
\n
(b) Non-Current Liabilities:
\n
\n
\n
\n
Lease Liability
\n
2
\n
\n
\n
367,148
\n
-
\n
\n
\n
367,148
\n
-
\n
Note:
\n
1
\n
Please refer to Note 6 for further discussion.
\n
\n
2
\n
During the period, the Company entered into an office lease which commenced on 29 July 2025 with the principal rent amount of \u00a3164,540
\n
($337,420) per annum commencing from the start date of the lease, expiring on 30 June 2028. Refer to Note 8 for the carrying amount of the
\n
right-of-use asset. The following are amounts recognised in the Statement of Profit and Loss: (i) amortisation expense of right-of-use asset
\n
$290,163 (2025: $262,380); (ii) interest expense on lease liabilities of $79,228 (2025: $13,285); and (iii) rent expense of $216,844 (2025: $95,950).
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfOtherCurrentLiabilitiesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag350": {
"value": "\n10. OTHER FINANCIAL LIABILITIES
\n
\nNote
\n2026
\n2025
\n
\n
\n$
\n$
\n
\n
\n
\n
\n(a) Current Liabilities:
\n
\n
\n
\nGrant received, E&E expenditures not yet incurred
\n1
\n
\n6
\n-
\n533,161
\nLease Liability
\n2
\n
\n
\n263,608
\n-
\n
\n
\n263,608
\n533,161
\n
\n
\n
\n
\n(b) Non-Current Liabilities:
\n
\n
\n
\nLease Liability
\n2
\n
\n
\n367,148
\n-
\n
\n
\n367,148
\n-
\nNote:
\n1
\n Please refer to Note 6 for further discussion.
\n
\n2
\n During the period, the Company entered into an office lease which commenced on 29 July 2025 with the principal rent amount of \u00a3164,540
\n($337,420) per annum commencing from the start date of the lease, expiring on 30 June 2028. Refer to Note 8 for the carrying amount of the
\nright-of-use asset. The following are amounts recognised in the Statement of Profit and Loss: (i) amortisation expense of right-of-use asset
\n$290,163 (2025: $262,380); (ii) interest expense on lease liabilities of $79,228 (2025: $13,285); and (iii) rent expense of $216,844 (2025: $95,950).
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag351": {
"value": "\n11. PROVISIONS
\n
\n
\n
\n2026
\n$
\n2025
\n$
\n
\n
\n
\n
\n(a) Current Provisions:
\n
\n
\n
\nProvisions for the protection against mining damage at Debiensko
\n1
\n
\n
\n536,221
\n772,727
\nAnnual leave provision
\n
\n11,594
\n5,029
\n
\n
\n547,815
\n777,756
\n
\n
\n
\n
\n(b) Non-Current Provisions:
\n
\n
\n
\nProvisions for the protection against mining damage at Debiensko
\n1
\n
\n
\n283,200
\n304,576
\n
\n
\n283,200
\n304,576
\nNotes:
\n1
\n As Debiensko was previously an operating mine, the Group has provided for the pay out of mining land damages to surrounding land owners
\nwho have made a legitimate legal claim under Polish law.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfProvisionsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag352": {
"value": "\n
\n\n
12. CONTRIBUTED EQUITY
\n
\n
\n
2026
\n
2025
\n
\n
Note
\n
$
\n
$
\n
\n
\n
\n
\n
(a) Issued and Unissued Capital
\n
\n
\n
\n
311,972,551 (2025: 287,083,089) fully paid Ordinary Shares
\n
12(b)
\n
113,962,053
\n
95,187,822
\n
Total Contributed Equity
\n
\n
113,962,053
\n
95,187,822
\n
\n
\n\n
\n\n\n
\n\n
(b) Movements in Ordinary Shares During the Past Two Years Were as Follows:
\n
\n
Date
\n
Details
\n
Number of
\n
Ordinary Shares
\n
$
\n
\n
\n
\n
\n
1 Jul 2025
\n
Opening balance
\n
287,083,089
\n
95,187,822
\n
28 Nov 25
\n
Exercise of $0.45 incentive options
\n
1,100,000
\n
495,000
\n
25 Nov 25
\n
Exercise of $0.45 incentive options (cashless)
\n
1,582,520
\n
-
\n
2 Dec 25
\n
Exercise of $0.45 incentive options (cashless)
\n
116,579
\n
-
\n
11 Dec 25
\n
Issue of Tannenberg acquisition consideration shares (Notes 6
\n
and7)
\n
3,487,147
\n
3,000,000
\n
30 Jan 2026
\n
Issue of ELN deferred consideration shares (Note 6)
\n
1,141,409
\n
1,000,000
\n
30 Jan 2026
\n
Issue of shares to a consultant
\n
220,000
\n
187,000
\n
10 Feb 2026
\n
Issue of placement shares
\n
16,000,000
\n
13,600,000
\n
13 Mar 2026
\n
Issue of shares to a consultant
\n
598,235
\n
508,500
\n
26 Jun 2026
\n
Exercise of $0.55 incentive options (cashless)
\n
643,572
\n
-
\n
Jul 25 to Jun 26
\n
Transfer from share-based payment reserve upon exercise of
\n
options
\n
-
\n
689,186
\n
Jul 25 to Jun 26
\n
Share issue costs
\n
-
\n
(705,455)
\n
30 Jun 2026
\n
Closing balance
\n
311,972,551
\n
113,962,053
\n
\n
\n
\n
\n
1 Jul 2024
\n
Opening balance
\n
278,901,032
\n
89,918,183
\n
2 Aug 24
\n
Issue of Tannenberg consideration (Note 6)
\n
500,000
\n
405,000
\n
2 Aug 24
\n
Issue of shares to a consultant
\n
100,000
\n
81,000
\n
18 Oct 24
\n
Issue of ELN consideration (Note 6)
\n
382,636
\n
300,000
\n
26 May 25
\n
Issue of placement Shares
\n
6,394,537
\n
4,156,449
\n
26 May 25
\n
Issue of shares to a consultant
\n
79,365
\n
51,587
\n
2 Jun 25
\n
Issue of placement Shares
\n
725,519
\n
471,587
\n
Jul 24 to Jun 25
\n
Share issue costs
\n
-
\n
(195,984)
\n
30 Jun 2025
\n
Closing balance
\n
287,083,089
\n
95,187,822
\n
(c) Rights Attaching to Ordinary Shares
\n
The rights attaching to fully paid Ordinary Shares arise from a combination of the Company's Constitution, statute
\n
and general law.
\n
Ordinary Shares issued following the exercise of Incentive Options in accordance with Note 13(d) or the conversion
\n
of Performance Rights in accordance with Note 13(c) will rank equally in all respects with the Company's existing
\n
Ordinary Shares.
\n
Copies of the Company's Constitution are available for inspection during business hours at the Company's
\n
registered office. The clauses of the Constitution contain the internal rules of the Company and define matters
\n
such as the rights, duties and powers of its shareholders and directors, including provisions to the following effect
\n
(when read in conjunction with the Corporations Act 2001 or Listing Rules).
\n
(i) Shares
\n
The issue of shares in the capital of the Company and options over unissued shares by the Company is under the
\n
control of the Directors, subject to the Corporations Act 2001, ASX Listing Rules and any rights attached to any
\n
special class of shares.
\n
(ii) Meetings of Members
\n
Directors may call a meeting of members whenever they think fit. Members may call a meeting as provided by the
\n
Corporations Act 2001. The Constitution contains provisions prescribing the content requirements of notices of
\n
meetings of members and all members are entitled to a notice of meeting. A meeting may be held in two or more
\n
places linked together by audio-visual communication devices. A quorum for a meeting of members is two
\n
shareholders.
\n
The Company holds annual general meetings in accordance with the Corporations Act 2001 and the Listing Rules.
\n
\n\n
\n\n\n
\n
\n\n
(iii) Voting
\n
Subject to any rights or restrictions at the time being attached to any shares or class of shares of the Company,
\n
each member of the Company is entitled to receive notice of, attend and vote at a general meeting. Resolutions
\n
of members will be decided by a poll.
\n
On a poll each eligible member has one vote for each fully paid share held and a fraction of a vote for each partly
\n
paid share determined by the amount paid up on that share.
\n
(iv) Changes to the Constitution
\n
The Company's Constitution can only be amended by a special resolution passed by at least three quarters of the
\n
members present and voting at a general meeting of the Company. At least 28 days' written notice specifying the
\n
intention to propose the resolution as a special resolution must be given.
\n
(v) Listing Rules
\n
Provided the Company remains admitted to the Official List, then despite anything in its Constitution, no act may
\n
be done that is prohibited by the Listing Rules, and authority is given for acts required to be done by the Listing
\n
Rules. The Company's Constitution will be deemed to comply with the Listing Rules as amended from time to
\n
time.
\n
\n\n
\n
13. RESERVES
\n
\n
\n
2026
\n
2025
\n
\n
Note
\n
$
\n
$
\n
\n
\n
\n
\n
Share-based-payments reserve
\n
13(b)
\n
1,758,598
\n
4,616,748
\n
Foreign currency translation reserve
\n
\n
226,738
\n
55,806
\n
Other equity reserve
\n
\n
6,128,860
\n
6,211,258
\n
\n
\n
8,114,196
\n
10,883,812
\n
\n
(a) Nature and Purpose of Reserves
\n
(i) Share-based payments reserve
\n
The share-based payments reserve is used to record the fair value of Incentive Options and Performance Rights
\n
issued by the Group.
\n
(ii) Foreign currency translation reserve
\n
Exchange differences arising on translation of foreign controlled entities are taken to the foreign currency
\n
translation reserve. The reserve is recognised in the Statement of Profit or Loss and other Comprehensive Income
\n
when the net investment is disposed of.
\n
(iii) Other equity reserve
\n
Equity transactions are recorded in the other equity reserve (e.g. movements of non-controlling interests).
\n
\n\n
\n\n\n
\n\n
(b) Movements in share-based payments reserve during the past two years were as follows:
\n
Date
\n
Details
\n
Number of
\n
Incentive
\n
Options
\n
Number of
\n
Performance
\n
Rights
\n
$
\n
\n
\n
\n
\n
\n
1 Jul 2025
\n
Opening Balance
\n
23,900,000
\n
11,000,000
\n
4,616,748
\n
30 Nov 2025
\n
Exercise of $0.45 incentive options
\n
(4,775,000)
\n
-
\n
(515,220)
\n
1 Sep 2025
\n
Issue of Incentive Options
\n
600,000
\n
-
\n
-
\n
31 Dec 2025
\n
Lapse of unvested Performance Rights
\n
(Note 6)
\n
-
\n
-
\n
(3,355,000)
\n
19 Jun 2026
\n
Lapse incentive options
\n
(800,000)
\n
-
\n
(36,438)
\n
26 Jun 2026
\n
Exercise of $0.55 incentive options
\n
(1,500,000)
\n
-
\n
(173,966)
\n
Jul 25 to Jun 26!
\n
Issue of Incentive Options
\n
9,500,000
\n
-
\n
-
\n
Jul 25 to Jun 26
\n
Share-based payments expense
\n
-
\n
-
\n
1,222,474
\n
30 Jun 2026
\n
Closing balance
\n
26,925,000
\n
11,000,000
\n
1,758,598
\n
\n
\n
\n
\n
\n
1 Jul 2024
\n
Opening Balance
\n
10,300,000
\n
11,000,000
\n
4,560,793
\n
13 Jun 25
\n
Issue of Incentive Options
\n
13,600,000
\n
-
\n
-
\n
Jul 24 to Jun 25
\n
Share-based payments expense
\n
-
\n
-
\n
55,955
\n
30 Jun 2025
\n
Closing balance
\n
23,900,000
\n
11,000,000
\n
4,616,748
\n
(c) Terms and Conditions of Incentive Options
\n
The unlisted incentive options (Incentive Options) were granted based upon the following terms and conditions:
\n
\u2022 Each Incentive Option entitles the holder to the right to subscribe for one Share upon the exercise of each
\n
Incentive Option;
\n
\u2022 The Incentive Options granted as share-based payments during the financial year have the following
\n
exercise prices and expiry dates:
\n
o 4,025,000 Incentive Options exercisable at $0.55 on or before 30 November 2026;
\n
o 7,600,000 Incentive Options exercisable at $1.05 on or before 31 May 2029;
\n
o 7,600,000 Incentive Options exercisable at $1.20 on or before 31 May 2030; and
\n
o 7,700,000 Incentive Options exercisable at $1.50 on or before 31 May 2031.
\n
\u2022 The Incentive Options are exercisable at any time prior to the Expiry Date, subject to vesting conditions
\n
being satisfied (if applicable);
\n
\u2022 Shares issued on exercise of the Incentive Options rank equally with the then Shares of the Company;
\n
\u2022 Application will be made by the Company to ASX for official quotation of the Shares issued upon the
\n
exercise of the Incentive Options;
\n
\u2022 If there is any reconstruction of the issued share capital of the Company, the rights of the Incentive Option
\n
holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time
\n
of the reconstruction; and
\n
\u2022 No application for quotation of the Incentive Options will be made by the Company.
\n
(d) Terms and Conditions of Performance Rights
\n
The unlisted performance rights (Performance Rights) were granted in prior years based upon the following
\n
terms and conditions:
\n
\u2022 Each Performance Right automatically converts into one Ordinary Share upon vesting of the Performance
\n
Right;
\n
\u2022 Each Performance Right is subject to performance conditions (as determined by the Board from time to
\n
time) which must be satisfied in order for the Performance Right to vest;
\n
\u2022 The Performance Rights outstanding at the end of the financial year have the following performance
\n
conditions and expiry dates:
\n
o 5,000,000 Class A performance rights which vest and convert into ordinary shares upon the
\n
announcement of an independently assessed JORC Code inferred resource of at least 250,000
\n
tonnes of copper equivalent at a minimum resource grade of 1% Cu Equivalent (with a cut-off grade
\n
of 0.5% Cu equivalent) at ARC and an expiry date 8 October 2026; and
\n
\n\n
\n\n\n
\n\n
o 6,000,000 Class B performance rights which vest and convert into ordinary shares upon the
\n
announcement of an independently assessed JORC Code inferred resource of at least 500,000
\n
tonnes of copper equivalent at a minimum resource grade of 1% Cu Equivalent (with a cut-off grade
\n
of 0.5% Cu equivalent) at ARC and an expiry date 8 October 2026.
\n
\u2022 During the year, it was determined that the performance conditions for the Class A and B performance
\n
rights will not be achieved and that performance rights will lapse on their expiry date;
\n
\u2022 Ordinary Shares issued on conversion of the Performance Rights rank equally with the then Ordinary
\n
Shares of the Company;
\n
\u2022 Application will be made by the Company to ASX for official quotation of the Ordinary Shares issued upon
\n
conversion of the Performance Rights;
\n
\u2022 If there is any reconstruction of the issued share capital of the Company, the rights of the Performance
\n
Right holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the
\n
time of the reconstruction;
\n
\u2022 No application for quotation of the Performance Rights will be made by the Company; and
\n
\u2022 Without approval of the Board, Performance Rights may not be transferred, assigned or novated, except,
\n
upon death, a participant's legal personal representative may elect to be registered as the new holder of
\n
such Performance Rights and exercise any rights in respect of them.
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag353": {
"value": "\n12. CONTRIBUTED EQUITY
\n
\n
\n2026
\n2025
\n
\nNote
\n$
\n$
\n
\n
\n
\n
\n(a) Issued and Unissued Capital
\n
\n
\n
\n311,972,551 (2025: 287,083,089) fully paid Ordinary Shares
\n12(b)
\n113,962,053
\n95,187,822
\nTotal Contributed Equity
\n
\n113,962,053
\n95,187,822
\n
\n
\n\n\n(b) Movements in Ordinary Shares During the Past Two Years Were as Follows:
\n
\nDate
\nDetails
\nNumber of
\nOrdinary Shares
\n$
\n
\n
\n
\n
\n1 Jul 2025
\n Opening balance
\n287,083,089
\n95,187,822
\n28 Nov 25
\nExercise of $0.45 incentive options
\n1,100,000
\n495,000
\n25 Nov 25
\nExercise of $0.45 incentive options (cashless)
\n1,582,520
\n-
\n2 Dec 25
\nExercise of $0.45 incentive options (cashless)
\n116,579
\n-
\n11 Dec 25
\nIssue of Tannenberg acquisition consideration shares (Notes 6
\nand7)
\n3,487,147
\n3,000,000
\n30 Jan 2026
\nIssue of ELN deferred consideration shares (Note 6)
\n1,141,409
\n1,000,000
\n30 Jan 2026
\nIssue of shares to a consultant
\n220,000
\n187,000
\n10 Feb 2026
\nIssue of placement shares
\n16,000,000
\n13,600,000
\n13 Mar 2026
\nIssue of shares to a consultant
\n598,235
\n508,500
\n26 Jun 2026
\nExercise of $0.55 incentive options (cashless)
\n643,572
\n-
\nJul 25 to Jun 26
\nTransfer from share-based payment reserve upon exercise of
\noptions
\n-
\n689,186
\nJul 25 to Jun 26
\nShare issue costs
\n-
\n(705,455)
\n30 Jun 2026
\nClosing balance
\n311,972,551
\n113,962,053
\n
\n
\n
\n
\n1 Jul 2024
\n Opening balance
\n278,901,032
\n89,918,183
\n2 Aug 24
\nIssue of Tannenberg consideration (Note 6)
\n500,000
\n405,000
\n2 Aug 24
\nIssue of shares to a consultant
\n100,000
\n81,000
\n18 Oct 24
\nIssue of ELN consideration (Note 6)
\n382,636
\n300,000
\n26 May 25
\nIssue of placement Shares
\n6,394,537
\n4,156,449
\n26 May 25
\nIssue of shares to a consultant
\n79,365
\n51,587
\n2 Jun 25
\nIssue of placement Shares
\n725,519
\n471,587
\nJul 24 to Jun 25
\nShare issue costs
\n-
\n(195,984)
\n30 Jun 2025
\nClosing balance
\n287,083,089
\n95,187,822
\n(c) Rights Attaching to Ordinary Shares
\nThe rights attaching to fully paid Ordinary Shares arise from a combination of the Company's Constitution, statute
\nand general law.
\nOrdinary Shares issued following the exercise of Incentive Options in accordance with Note 13(d) or the conversion
\nof Performance Rights in accordance with Note 13(c) will rank equally in all respects with the Company's existing
\nOrdinary Shares.
\nCopies of the Company's Constitution are available for inspection during business hours at the Company's
\nregistered office. The clauses of the Constitution contain the internal rules of the Company and define matters
\nsuch as the rights, duties and powers of its shareholders and directors, including provisions to the following effect
\n(when read in conjunction with the Corporations Act 2001 or Listing Rules).
\n(i) Shares
\nThe issue of shares in the capital of the Company and options over unissued shares by the Company is under the
\ncontrol of the Directors, subject to the Corporations Act 2001, ASX Listing Rules and any rights attached to any
\nspecial class of shares.
\n(ii) Meetings of Members
\nDirectors may call a meeting of members whenever they think fit. Members may call a meeting as provided by the
\nCorporations Act 2001. The Constitution contains provisions prescribing the content requirements of notices of
\nmeetings of members and all members are entitled to a notice of meeting. A meeting may be held in two or more
\nplaces linked together by audio-visual communication devices. A quorum for a meeting of members is two
\nshareholders.
\nThe Company holds annual general meetings in accordance with the Corporations Act 2001 and the Listing Rules.
\n
\n\n\n(iii) Voting
\nSubject to any rights or restrictions at the time being attached to any shares or class of shares of the Company,
\neach member of the Company is entitled to receive notice of, attend and vote at a general meeting. Resolutions
\nof members will be decided by a poll.
\nOn a poll each eligible member has one vote for each fully paid share held and a fraction of a vote for each partly
\npaid share determined by the amount paid up on that share.
\n(iv) Changes to the Constitution
\nThe Company's Constitution can only be amended by a special resolution passed by at least three quarters of the
\nmembers present and voting at a general meeting of the Company. At least 28 days' written notice specifying the
\nintention to propose the resolution as a special resolution must be given.
\n(v) Listing Rules
\nProvided the Company remains admitted to the Official List, then despite anything in its Constitution, no act may
\nbe done that is prohibited by the Listing Rules, and authority is given for acts required to be done by the Listing
\nRules. The Company's Constitution will be deemed to comply with the Listing Rules as amended from time to
\ntime.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag358": {
"value": "\n13. RESERVES
\n
\n
\n2026
\n2025
\n
\nNote
\n$
\n$
\n
\n
\n
\n
\nShare-based-payments reserve
\n13(b)
\n1,758,598
\n4,616,748
\nForeign currency translation reserve
\n
\n226,738
\n55,806
\nOther equity reserve
\n
\n6,128,860
\n6,211,258
\n
\n
\n8,114,196
\n10,883,812
\n
\n(a) Nature and Purpose of Reserves
\n(i) Share-based payments reserve
\nThe share-based payments reserve is used to record the fair value of Incentive Options and Performance Rights
\nissued by the Group.
\n(ii) Foreign currency translation reserve
\nExchange differences arising on translation of foreign controlled entities are taken to the foreign currency
\ntranslation reserve. The reserve is recognised in the Statement of Profit or Loss and other Comprehensive Income
\nwhen the net investment is disposed of.
\n(iii) Other equity reserve
\nEquity transactions are recorded in the other equity reserve (e.g. movements of non-controlling interests).
\n
\n\n\n(b) Movements in share-based payments reserve during the past two years were as follows:
\nDate
\nDetails
\nNumber of
\nIncentive
\nOptions
\nNumber of
\nPerformance
\nRights
\n$
\n
\n
\n
\n
\n
\n1 Jul 2025
\nOpening Balance
\n23,900,000
\n11,000,000
\n4,616,748
\n30 Nov 2025
\nExercise of $0.45 incentive options
\n(4,775,000)
\n-
\n(515,220)
\n1 Sep 2025
\nIssue of Incentive Options
\n600,000
\n-
\n-
\n31 Dec 2025
\nLapse of unvested Performance Rights
\n(Note 6)
\n-
\n-
\n(3,355,000)
\n19 Jun 2026
\nLapse incentive options
\n(800,000)
\n-
\n(36,438)
\n26 Jun 2026
\nExercise of $0.55 incentive options
\n(1,500,000)
\n-
\n(173,966)
\nJul 25 to Jun 26!
\nIssue of Incentive Options
\n9,500,000
\n-
\n-
\nJul 25 to Jun 26
\nShare-based payments expense
\n-
\n-
\n1,222,474
\n30 Jun 2026
\nClosing balance
\n26,925,000
\n11,000,000
\n1,758,598
\n
\n
\n
\n
\n
\n1 Jul 2024
\nOpening Balance
\n10,300,000
\n11,000,000
\n4,560,793
\n13 Jun 25
\nIssue of Incentive Options
\n13,600,000
\n-
\n-
\nJul 24 to Jun 25
\nShare-based payments expense
\n-
\n-
\n55,955
\n30 Jun 2025
\nClosing balance
\n23,900,000
\n11,000,000
\n4,616,748
\n(c) Terms and Conditions of Incentive Options
\nThe unlisted incentive options (Incentive Options) were granted based upon the following terms and conditions:
\n\u2022 Each Incentive Option entitles the holder to the right to subscribe for one Share upon the exercise of each
\nIncentive Option;
\n\u2022 The Incentive Options granted as share-based payments during the financial year have the following
\nexercise prices and expiry dates:
\no 4,025,000 Incentive Options exercisable at $0.55 on or before 30 November 2026;
\no 7,600,000 Incentive Options exercisable at $1.05 on or before 31 May 2029;
\no 7,600,000 Incentive Options exercisable at $1.20 on or before 31 May 2030; and
\no 7,700,000 Incentive Options exercisable at $1.50 on or before 31 May 2031.
\n\u2022 The Incentive Options are exercisable at any time prior to the Expiry Date, subject to vesting conditions
\nbeing satisfied (if applicable);
\n\u2022 Shares issued on exercise of the Incentive Options rank equally with the then Shares of the Company;
\n\u2022 Application will be made by the Company to ASX for official quotation of the Shares issued upon the
\nexercise of the Incentive Options;
\n\u2022 If there is any reconstruction of the issued share capital of the Company, the rights of the Incentive Option
\nholders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time
\nof the reconstruction; and
\n\u2022 No application for quotation of the Incentive Options will be made by the Company.
\n(d) Terms and Conditions of Performance Rights
\nThe unlisted performance rights (Performance Rights) were granted in prior years based upon the following
\nterms and conditions:
\n\u2022 Each Performance Right automatically converts into one Ordinary Share upon vesting of the Performance
\nRight;
\n\u2022 Each Performance Right is subject to performance conditions (as determined by the Board from time to
\ntime) which must be satisfied in order for the Performance Right to vest;
\n\u2022 The Performance Rights outstanding at the end of the financial year have the following performance
\nconditions and expiry dates:
\no 5,000,000 Class A performance rights which vest and convert into ordinary shares upon the
\nannouncement of an independently assessed JORC Code inferred resource of at least 250,000
\ntonnes of copper equivalent at a minimum resource grade of 1% Cu Equivalent (with a cut-off grade
\nof 0.5% Cu equivalent) at ARC and an expiry date 8 October 2026; and
\n
\n\n\no 6,000,000 Class B performance rights which vest and convert into ordinary shares upon the
\nannouncement of an independently assessed JORC Code inferred resource of at least 500,000
\ntonnes of copper equivalent at a minimum resource grade of 1% Cu Equivalent (with a cut-off grade
\nof 0.5% Cu equivalent) at ARC and an expiry date 8 October 2026.
\n\u2022 During the year, it was determined that the performance conditions for the Class A and B performance
\nrights will not be achieved and that performance rights will lapse on their expiry date;
\n\u2022 Ordinary Shares issued on conversion of the Performance Rights rank equally with the then Ordinary
\nShares of the Company;
\n\u2022 Application will be made by the Company to ASX for official quotation of the Ordinary Shares issued upon
\nconversion of the Performance Rights;
\n\u2022 If there is any reconstruction of the issued share capital of the Company, the rights of the Performance
\nRight holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the
\ntime of the reconstruction;
\n\u2022 No application for quotation of the Performance Rights will be made by the Company; and
\n\u2022 Without approval of the Board, Performance Rights may not be transferred, assigned or novated, except,
\nupon death, a participant's legal personal representative may elect to be registered as the new holder of
\nsuch Performance Rights and exercise any rights in respect of them.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag363": {
"value": "\n14. EARNINGS PER SHARE
\nThe following reflects the income and share data used in the calculations of basic and diluted earnings per share:
\n
\n2026
\n$
\n2025
\n$
\nNet loss attributable to members of the Parent used in calculating basic and
\ndiluted earnings per share
\n(12,204,736)
\n(6,014,885)
\n
\nNumber of
\nOrdinary Shares
\n2026
\nNumber of
\nOrdinary Shares
\n2025
\nWeighted average number of Ordinary Shares used in calculating basic and diluted
\nloss per share
\n297,771,393
\n280,527,231
\n
\n
\n2026
\nCents
\n2025
\nCents
\nBasic and diluted loss per share
\n(4.10)
\n(2.14)
\n(a) Non-Dilutive Securities
\nAs at 30 June 2026, there were 26,925,000 (2025: 23,900,000) Incentive Options and 11,000,000 (2025: 11,000,000)
\nunlisted Performance Rights on issue (which together represent 37,925,000 (2025: 34,900,000) potential Ordinary
\nShares) which were not considered dilutive as they would decrease the loss per share.
\n(b) Conversions, Calls, Subscriptions or Issues after 30 June 2026
\nThere have been no other conversions to, calls of, or subscriptions for Ordinary Shares or issues of potential
\nOrdinary Shares since the reporting date and before the completion of this financial report.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:EarningsPerShareExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag364": {
"value": "\n
\n15. STATEMENT OF CASH FLOWS
\n(a) Reconciliation of the Profit after Tax to the Net Cash Flows from Operations
\n
\n
\n2026
\n2025
\n
\n
\n$
\n$
\n
\n
\n
\n
\nNet loss for the year
\n
\n(12,339,989)
\n(6,022,365)
\n
\n
\n
\n
\nAdjustments
\n
\n
\n
\nDepreciation and amortisation
\n
\n298,783
\n268,536
\nShare-based payment expense
\n
\n1,373,037
\n136,955
\nUnrealised foreign exchange movement
\n
\n(42,223)
\n(27,483)
\nPayment for lease liability (financing activity)
\n
\n331,477
\n49,927
\nNon-cash income
\n
\n-
\n(251,593)
\nNon-cash expenditure
\n
\n-
\n1,519,171
\nImpairment loss
\n
\n4,415,000
\n-
\n
\n
\n
\n
\nChange in operating assets and liabilities
\n
\n
\n
\nIncrease in trade and other receivables
\n
\n(30,635)
\n(354,954)
\nDecrease in trade and other payables
\n
\n(251,442)
\n(98,941)
\n
\n
\n
\n
\nNet cash outflow from operating activities
\n
\n(6,245,992)
\n(4,780,747)
\n
\n
\n
\n\n
\n
(b) Reconciliation of Cash
\n
\n
\n
\n
Cash at bank and on hand
\n
\n
7,417,445
\n
6,826,337
\n
Bank short term deposits
\n
\n
6,000,000
\n
-
\n
\n
\n
13,417,445
\n
6,826,337
\n
\n\n
(c) Non-cash Financing and Investment Activities
\nDuring the period, no amount (2025: $251,593) was recognised as arbitration related income. These amounts relate
\nto the reimbursement of legal, tribunal and external expert costs relating to the claim. None (2025: $251,593) of
\nthese reimbursed amounts were paid directly by the Claim funder to the relevant supplier.
\nDuring the period, 598,235 Ordinary Shares (2025: nil) were issued as share-based payments consideration for
\nassistance provided in completing the placement undertaken during the year. The value of these shares was
\nrecognised as a share issue cost.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag365": {
"value": "\n
\n(b) Reconciliation of Cash
\n
\n
\n
\nCash at bank and on hand
\n
\n7,417,445
\n6,826,337
\nBank short term deposits
\n
\n6,000,000
\n-
\n
\n
\n13,417,445
\n6,826,337
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag366": {
"value": "\n
\n16. RELATED PARTIES
\n\n
(a) Subsidiaries
\n
\n
\n
% Equity Interest
\n
Name
\n
Country of
\n
Incorporation
\n
2026
\n
%
\n
2025
\n
%
\n
\n
\n
\n
\n
Mineral Investments Pty Ltd
\n
Australia
\n
100
\n
100
\n
PDZ Holdings Pty Ltd
\n
Australia
\n
100
\n
100
\n
GreenX Holdings Pty Ltd
\n
Australia
\n
100
\n
100
\n
GreenX Investments Pty Ltd
\n
Australia
\n
100
\n
100
\n
PDZ (UK) Limited
\n
UK
\n
100
\n
100
\n
PD CO Holdings (UK) Limited
\n
UK
\n
100
\n
100
\n
GreenX Holdings (UK) Limited
\n
UK
\n
100
\n
100
\n
GreenX Investments (UK) Limited
\n
UK
\n
100
\n
100
\n
PD Co Sp. z o.o.
\n
Poland
\n
100
\n
100
\n
Karbonia S.A.
\n
Poland
\n
100
\n
100
\n
Group 11 Exploration GmbH
\n
Germany
\n
90
\n
-
\n
ARC Joint Venture Company ApS
\n
Greenland
\n
100
\n
51
\n
\n\n
(b) Ultimate Parent
\nGreenX Metals Limited is the ultimate parent of the Group.
\n
\n\n\n(c) Transactions with Related Parties
\nBalances and transactions between the Company and its subsidiaries, which are related parties of the Company,
\nhave been eliminated on consolidation and are not disclosed in this note. Transactions with KMP, including
\nremuneration, are included at Note 17 below.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag367": {
"value": "\n(a) Subsidiaries
\n
\n
\n% Equity Interest
\nName
\nCountry of
\nIncorporation
\n2026
\n%
\n2025
\n%
\n
\n
\n
\n
\nMineral Investments Pty Ltd
\nAustralia
\n100
\n100
\nPDZ Holdings Pty Ltd
\nAustralia
\n100
\n100
\nGreenX Holdings Pty Ltd
\nAustralia
\n100
\n100
\nGreenX Investments Pty Ltd
\nAustralia
\n100
\n100
\nPDZ (UK) Limited
\nUK
\n100
\n100
\nPD CO Holdings (UK) Limited
\nUK
\n100
\n100
\nGreenX Holdings (UK) Limited
\nUK
\n100
\n100
\nGreenX Investments (UK) Limited
\nUK
\n100
\n100
\nPD Co Sp. z o.o.
\nPoland
\n100
\n100
\nKarbonia S.A.
\nPoland
\n100
\n100
\nGroup 11 Exploration GmbH
\nGermany
\n90
\n-
\nARC Joint Venture Company ApS
\nGreenland
\n100
\n51
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag368": {
"value": "Australia",
"dimensions": {
"concept": "ifrs-full:CountryOfIncorporation",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag369": {
"value": "Australia",
"dimensions": {
"concept": "ifrs-full:PrincipalPlaceOfBusiness",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag370": {
"value": "GreenX Metals Limited",
"dimensions": {
"concept": "ifrs-full:NameOfUltimateParentOfGroup",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag372": {
"value": "\n17. KEY MANAGEMENT PERSONNEL
\n(a) Details of KMP
\nThe KMP of the Group during or since the end of the financial year were as follows:
\n
\nCurrent Directors
\nMr Ian Middlemas Chairman
\nMr Benjamin Stoikovich Director and CEO
\nMr Garry Hemming Non-Executive Director
\nMr Mark Pearce Non-Executive Director
\nOther KMP
\nMr Simon Kersey Chief Financial Officer
\nMr Dylan Browne Company Secretary
\nUnless otherwise disclosed, the KMP held their position from 1 July 2025 until the date of this report.
\n
\n
\n
\n2026
\n2025
\n
\n
\n$
\n$
\n
\n
\n
\n
\nShort-term employee benefits
\n
\n924,414
\n939,564
\nPost-employment benefits
\n
\n6,720
\n6,440
\nShare-based payments
\n
\n532,235
\n25,108
\nTotal compensation
\n
\n1,463,369
\n971,112
\n(b) Loans from KMP
\nNo loans were provided to or received from KMP during the year ended 30 June 2026 (2025: Nil).
\n(c) Other Transactions
\nApollo Group, a company of which Mr Mark Pearce is a Director and beneficial shareholder, was paid or is payable
\n$330,000 (2025: $312,000) for the provision of administrative, secretarial and corporate services to the Group. This
\nitem has been recognised as an expense in the Statement of Profit or Loss and other Comprehensive Income. The
\namount is based on a current monthly retainer of $27,500 (2025: $26,000) due and payable in advance, with no
\nfixed term, and is able to be terminated by either party with one month\u2019s notice.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag373": {
"value": "\n18. PARENT ENTITY DISCLOSURES
\n
\n2026
\n2025
\n
\n$
\n$
\n(a) Financial Position
\n
\n
\nAssets
\n
\n
\nCurrent assets
\n13,643,740
\n7,066,219
\nNon-current assets
\n5,570,200
\n5,233,390
\nTotal assets
\n19,213,940
\n12,299,609
\n
\n
\n
\nLiabilities
\n
\n
\nCurrent liabilities
\n897,560
\n536,212
\nNon-current liabilities
\n367,148
\n-
\nTotal liabilities
\n1,264,708
\n536,212
\n
\n
\n
\nEquity
\n
\n
\nContributed equity
\n113,989,366
\n95,215,134
\nReserves
\n7,966,092
\n10,824,241
\nAccumulated losses
\n(104,006,225)
\n(94,275,979)
\nTotal equity
\n17,949,233
\n11,763,396
\n
\n
\n
\n(b) Financial Performance
\n
\n
\nLoss for the year
\n(9,730,246)
\n(4,607,519)
\nOther comprehensive loss
\n-
\n-
\nTotal comprehensive loss
\n(9,730,246)
\n(4,607,519)
\n(c) Other information
\nThe Company has not entered into any guarantees in relation to its subsidiaries. Refer to Note 23 for details of
\ncontingent assets and liabilities.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag374": {
"value": "\n19. SHARE-BASED PAYMENTS
\n(a) Recognised Share-based Payments
\nFrom time to time, the Group provides Incentive Options and Performance Rights to officers, employees,
\nconsultants and other key advisors as part of remuneration and incentive arrangements. The number of options
\nor rights granted, and the terms of the options or rights granted are determined by the Board. Shareholder
\napproval is sought where required. During the past two years, the following equity-settled share-based payments
\nhave been recognised:
\n
\n2026
\n2025
\n
\n$
\n$
\nExpense arising from equity-settled share-based payment transactions
\n(1,373,037)
\n(136,955)
\nTotal share-based payments recognised during the year
\n(1,373,037)
\n(136,955)
\nIn addition to share-based payment expenses recognised as an expense through profit or loss:
\n\u2022 $3,000,000 recognised as an asset (exploration and evaluation assets) for issue of 3,487,147 ordinary shares
\nrelating to Tannenberg. Refer to notes 6 and 12 for further details; and
\n\u2022 $1,000,000 recognised as an asset (exploration and evaluation assets) for issue of 1,141,409 ordinary shares
\nrelating to ELN. Refer to notes 6 and 12 for further details.
\n
\n\n\n(b) Summary of Incentive Options Granted as Share-based Payments
\nThe following Incentive Options were granted as share-based payments during the current year and 2025.
\n2026
\nNumber
\nGrant Date
\nIssue Date
\nExpiry Date
\nExercise Price
\n$
\nFair Value
\n
\n$
\nSeries 1
\n300,000
\n1 Sep 2025
\n1 Sep 2025
\n31 May 2029
\n1.05
\n0.303
\nSeries 2
\n300,000
\n1 Sep 2025
\n1 Sep 2025
\n31 May 2030
\n1.20
\n0.328
\nSeries 3
\n600,000
\n16 Apr 2026
\n16 Apr 2026
\n31 May 2029
\n1.05
\n0.381
\nSeries 4
\n600,000
\n16 Apr 2026
\n16 Apr 2026
\n31 May 2030
\n1.20
\n0.412
\nSeries 5
\n1,000,000
\n27 May 2026
\n4 June 2026
\n31 May 2031
\n1.50
\n0.387
\nSeries 6
\n300,000
\n4 June 2026
\n4 June 2026
\n31 May 2029
\n1.05
\n0.380
\nSeries 7
\n300,000
\n4 June 2026
\n4 June 2026
\n31 May 2030
\n1.20
\n0.408
\nSeries 8
\n4,600,000
\n4 June 2026
\n4 June 2026
\n31 May 2031
\n1.50
\n0.411
\nSeries 9
\n2,100,000
\n14 July 2026
\n1
\n
\n27 May 2026
\n1
\n
\n31 May 2031
\n1.50
\n0.374
\nNote:
\n1
\n Incentive Options issued to Directors following shareholder approval on 14 July 2026, following agreement to issue Incentive Options on 27
\nMay 2026.
\n
\n2025
\nNumber
\nGrant Date
\nStart Date
\nExpiry Date
\nExercise Price
\n$
\nFair Value
\n
\n$
\nSeries 1
\n5,000,000
\n13 June 2025
\n13 June 2025
\n31 May 2029
\n1.05
\n0.372
\nSeries 2
\n5,000,000
\n13 June 2025
\n13 June 2025
\n31 May 2030
\n1.20
\n0.378
\nSeries 1
\n1,800,000
\n29 July 2025
\n1
\n
\n13 June 2025
\n31 May 2029
\n1.05
\n0.371
\nSeries 2
\n1,800,000
\n29 July 2025
\n1
\n
\n13 June 2025
\n31 May 2030
\n1.20
\n0.397
\nNote:
\n1
\n Incentive Options issued to Directors following shareholder approval on 29 July 2025, following agreement to issue Incentive Options on 13
\nJune 2025.
\nThe following table illustrates the number and weighted average exercise prices (WAEP) of Incentive Options
\ngranted as share-based payments during the past two years:
\nIncentive Options
\n2026
\nNumber
\n2026
\nWAEP
\n2025
\nNumber
\n2025
\nWAEP
\nOutstanding at beginning of year
\n23,900,000
\n0.86
\n10,300,000
\n0.50
\nGranted by the Company during the year
\n10,100,000
\n1.412
\n13,600,000
\n0.94
\nExercised
\n(6,275,000)
\n0.474
\n-
\n-
\nCancelled
\n(800,000)
\n1.125
\n-
\n-
\nOutstanding at end of year
\n26,925,000
\n1.146
\n23,900,000
\n0.86
\nNo Performance Rights were granted as share-based payments during the current year (2024: nil).
\nThe following table illustrates the number and WAEP of Performance Rights granted as share-based payments at
\nduring the past two years:
\nPerformance Rights
\n2026
\nNumber
\n2026
\nWAEP
\n2025
\nNumber
\n2025
\nWAEP
\nOutstanding at beginning of year
\n11,000,000
\n-
\n11,000,000
\n-
\nGranted by the Company during the year
\n-
\n-
\n-
\n-
\nConverted/cancelled/expired
\n-
\n-
\n-
\n-
\nOutstanding at end of year (Note 6)
\n11,000,000
\n-
\n11,000,000
\n-
\n(c) Option Pricing Model
\nThe fair value of the equity-settled share Incentive Options granted is estimated as at the date of grant using the
\nBlack Scholes option pricing valuation model taking into account the terms and conditions upon which the
\nIncentive Options were granted.
\nDuring the year 10,100,000 (2025: 13,600,000) Incentive Options were granted as share-based payments in the
\nfinancial year ended 30 June 2026.
\nThe following table lists the inputs to the valuation models used for Incentive Options granted by the Group during
\nthe last two years:
\n
\n\n\nIncentive Options
\n2026 Inputs
\nSeries 1
\nSeries 2
\nSeries 3
\n
\nSeries 4
\n
\nSeries 5
\n
\nSeries 6
\nExercise price (A$)
\n1.05
\n1.20
\n1.05
\n1.20
\n1.50
\n1.05
\nGrant date share price (A$)
\n0.70
\n0.70
\n0.89
\n0.89
\n0.91
\n0.94
\nDividend yield
\n1
\n
\n-
\n-
\n-
\n-
\n-
\n-
\nVolatility
\n2
\n
\n70%
\n70%
\n65%
\n65%
\n60%
\n60%
\nRisk-free interest rate
\n3.40%
\n3.40%
\n4.62%
\n4.62%
\n4.50%
\n4.56%
\nGrant date
\n1 Sep 25
\n1 Sep 25
\n16 Apr 26
\n16 Apr 26
\n27 May 26
\n4 Jun 26
\nExpiry date
\n31 May 29
\n31 May 30
\n31 May 29
\n31 May 30
\n31 May 31
\n31 May 29
\nExpected life of rights
\n3
\n(years)
\n3.75
\n4.75
\n3.13
\n4.13
\n5.01
\n2.99
\nFair value at grant date (A$)
\n0.303
\n0.328
\n0.381
\n0.412
\n0.387
\n0.380
\n
\n
\nSeries 7
\n
\nSeries 8
\n
\nSeries 9
\nExercise price (A$)
\n1.20
\n1.50
\n1.50
\nGrant date share price (A$)
\n0.94
\n0.94
\n0.90
\nDividend yield
\n1
\n
\n-
\n-
\n-
\nVolatility
\n2
\n
\n60%
\n60%
\n60%
\nRisk-free interest rate
\n4.56%
\n4.56%
\n4.50%
\nGrant date
\n4 Jun 26
\n4 Jun 26
\n14 Jul 26
\nExpiry date
\n31 May 30
\n31 May 31
\n31 May 31
\nExpected life of rights
\n3
\n(years)
\n3.99
\n4.99
\n4.88
\nFair value at grant date (A$)
\n0.408
\n0.411
\n0.374
\n
\nIncentive Options
\n2025 Inputs
\nSeries 1
\nSeries 2
\nSeries 3
\n
\nSeries 4
\nExercise price (A$)
\n1.05
\n1.20
\n1.05
\n1.20
\nGrant date share price (A$)
\n0.72
\n0.72
\n0.79
\n0.79
\nDividend yield
\n1
\n
\n-
\n-
\n-
\n-
\nVolatility
\n2
\n
\n75%
\n75%
\n70%
\n70%
\nRisk-free interest rate
\n3.29%
\n3.29%
\n3.38%
\n3.38%
\nGrant date
\n13 Jun 25
\n13 Jun 25
\n29 Jul 25
\n29 Jul 25
\nExpiry date
\n31 May 29
\n31 May 30
\n31 May 29
\n31 May 30
\nExpected life of rights
\n3
\n(years)
\n3.97
\n4.97
\n3.38
\n4.84
\nFair value at grant date (A$)
\n0.352
\n0.378
\n0.371
\n0.397
\nNotes:
\n1
\n The dividend yield reflects the assumption that the current dividend payout will remain unchanged.
\n2
\n The expected volatility reflects the assumption that the historical volatility is indicative of future trends, which may not necessarily be the actual
\noutcome.
\n3
\n The expected life of the Incentive Options is based on the exercise date.
\n(d) Weighted Average Remaining Contractual Life
\nAt 30 June 2026, the weighted average remaining contractual life for Incentive Options on issue that had been
\ngranted as share-based payments was 3.40 years (2025: 2.93 years).
\n(e) Range of Exercise Prices
\nAt 30 June 2026, the range of exercise prices for Incentive Options on issue that had been granted as share-based
\npayments was $0.55 and $1.50 (2025: $0.45 and $1.20)
\n(f) Weighted Average Fair Value
\nDuring the year 10,100,000 Incentive Options granted as share-based payments during the year ended 30 June
\n2026 (2025: 13,600,000). The weighted average fair value of Incentive Options granted as share-based payments
\nduring the year ended 30 June 2026 was $0.392 (2025: 0.261).
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag377": {
"value": "\n20. AUDITORS\u2019 REMUNERATION
\nThe auditor of GreenX Metals Limited is UHY Haines Norton.
\n
\n2026
\n2025
\n
\n$
\n$
\nCurrent Auditor \u2013 UHY
\n
\n
\nAmounts received or due and receivable by UHY Haines Norton for:
\n
\n
\n\u2022 UHY Haines Norton \u2013 Australia: an audit or review of the financial report of the
\nCompany and any other entity in the consolidated group
\n136,887
\n135,961
\n\u2022 UHY Poland: an audit or review of the financial report of the Company and any other
\nentity in the consolidated group for WSE purposes
\n66,028
\n71,672
\n\u2022 Other entities: an audit or review of the financial report of any other entity in the
\nconsolidated group
\n3,841
\n4,223
\n
\n206,756
\n211,856
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag378": {
"value": "\n21. SEGMENT INFORMATION
\nThe Consolidated Entity operates in one segment, being mineral exploration. This is the basis on which internal
\nreports are provided to the Directors for assessing performance and determining the allocation of resources within
\nthe Consolidated Entity.
\n
\n2026
\n2025
\n
\n$
\n$
\n
\n
\n
\n(a) Reconciliation of Non-Current Assets by Geographical Location
\n
\n
\nGreenland
\n2,902,906
\n9,672,906
\nGermany
\n4,147,712
\n990,279
\nUnited Kingdom
\n637,213
\n236,835
\n
\n7,687,831
\n10,900,020
\n
\n
\n
\n(b) Revenue by Geographical Location
\n
\n
\nPoland
\n-
\n-
\nGreenland
\n-
\n435
\nAustralia
\n1,852,366
\n523,508
\n
\n1,852,366
\n523,943
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag379": {
"value": "\n
\n22. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES
\n(a) Overview
\nThe Group's principal financial instruments comprise receivables, payables, cash and short-term deposits. The
\nmain risks arising from the Group's financial instruments are credit risk, liquidity risk, interest rate risk and foreign
\ncurrency risk.
\nThis note presents information about the Group's exposure to each of the above risks, its objectives, policies and
\nprocesses for measuring and managing risk, and the management of capital. Other than as disclosed, there have
\nbeen no significant changes since the previous financial year to the exposure or management of these risks.
\nThe Group manages its exposure to key financial risks in accordance with the Group's financial risk management
\npolicy. Key risks are monitored and reviewed as circumstances change (e.g. acquisition of a new project) and
\npolicies are revised as required. The overall objective of the Group's financial risk management policy is to support
\nthe delivery of the Group's financial targets whilst protecting future financial security.
\nGiven the nature and size of the business and uncertainty as to the timing and amount of cash inflows and
\noutflows, the Group does not enter into derivative transactions to mitigate the financial risks. In addition, the
\nGroup's policy is that no trading in financial instruments shall be undertaken for the purposes of making
\nspeculative gains. As the Group's operations change, the Directors will review this policy periodically going forward.
\nThe Board of Directors has overall responsibility for the establishment and oversight of the risk management
\nframework. The Board reviews and agrees policies for managing the Group's financial risks as summarised below.
\n\n
(b) Credit Risk
\n
Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to
\n
meet its contractual obligations. This arises principally from cash and cash equivalents and trade and other
\n
receivables. There are no significant concentrations of credit risk within the Group. The carrying amount of the
\n
Group's financial assets represents the maximum credit risk exposure, as represented below:
\n
\n\n
\n\n\n
\n
\n
\n\n
\n
2026
\n
2025
\n
\n
$
\n
$
\n
Cash and cash equivalents
\n
13,417,445
\n
6,826,337
\n
Trade and other receivables
\n
545,528
\n
559,586
\n
\n
13,962,973
\n
7,385,923
\n
With respect to credit risk arising from cash and cash equivalents, the Group's exposure to credit risk arises from
\n
default of the counter party, with a maximum exposure equal to the carrying amount of these instruments. Where
\n
possible, the Group invests its cash and cash equivalents with banks that are rated the equivalent of investment
\n
grade and above. The Group\u2019s exposure and the credit ratings of its counterparties are continuously monitored
\n
and the aggregate value of transactions concluded is spread amongst approved counterparties.
\n
The Group does not have any significant customers and accordingly does not have significant exposure to bad or
\n
doubtful debts.
\n
Trade and other receivables comprise trade and other receivables, interest accrued and GST refunds due.
\n
Receivable balances are monitored on an ongoing basis with the result that the Group\u2019s exposure to impairment
\n
is not significant. At 30 June 2026, none (2025: none) of the Group\u2019s receivables are impaired.
\n
\n\n
\n
(c) Liquidity Risk
\n
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. The Board's
\n
approach to managing liquidity is to ensure, as far as possible, that the Group will always have sufficient liquidity
\n
to meet its liabilities when due. At 30 June 2026 and 2025, the Group had sufficient liquid assets to meet its financial
\n
obligations.
\n
The contractual maturities of financial liabilities, including estimated interest payments, are provided below. There
\n
are no netting arrangements in respect of financial liabilities.!
\n
\n
\u22646 Months
\n
$
\n
6-12 Months
\n
$
\n
1-5 Years
\n
$
\n
\u22655 Years
\n
$
\n
Total
\n
$
\n
2026
\n
\n
\n
\n
\n
\n
Financial Liabilities
\n
\n
\n
\n
\n
\n
Trade and other payables
\n
2,318,612
\n
-
\n
-
\n
-
\n
2,318,612
\n
Other financial liabilities
\n
128,643
\n
134,965
\n
367,148
\n
-
\n
630,756
\n
\n
2,447,255
\n
134,965
\n
367,148
\n
-
\n
2,949,368
\n
2025
\n
\n
\n
\n
\n
\n
Financial Liabilities
\n
\n
\n
\n
\n
\n
Trade and other payables
\n
2,347,703
\n
-
\n
-
\n
-
\n
2,347,703
\n
Other financial liabilities
\n
-
\n
-
\n
-
\n
-
\n
-
\n
\n
2,347,703
\n
\n
-
\n
-
\n
2,347,703
\n
\n\n
\n
(d) Interest Rate Risk
\n
The Group's exposure to the risk of changes in market interest rates relates primarily to the cash and short-term
\n
deposits with a variable interest rate.
\n
These financial assets with variable rates expose the Group to cash flow interest rate risk. All other financial assets
\n
and liabilities, in the form of receivables and payables are non-interest bearing.
\n
At the reporting date, the Group's exposure to variable interest rates was:
\n
\n
2026
\n
2025
\n
\n
$
\n
$
\n
Interest-bearing financial instruments
\n
\n
\n
Cash at bank and on hand
\n
7,417,445
\n
6,826,337
\n
Bank short term deposits
\n
6,000,000
\n
-
\n
\n
13,417,445
\n
6,826,337
\n
The Group's cash at bank and on hand and short term deposits had a weighted average floating interest rate at
\n
year end of 2.22 % (2025: 3.99%).
\n
The Group currently does not engage in any hedging or derivative transactions to manage interest rate risk.
\n
\n\n
\n\n\n
\n
\n
\n\n
Interest rate sensitivity
\n
A sensitivity of 3% (300 basis points) has been selected as this is considered reasonable given the current level of
\n
both short term and long term interest rates. A 3% (300 basis points) movement in interest rates at the reporting
\n
date would have increased/(decreased) Profit or Loss and Other Comprehensive Income by the amounts shown
\n
below. This analysis assumes that all other variables, in particular foreign currency rates, remain constant. The
\n
analysis is performed on a sensitivity of 3% (300 basis points) basis for 2026.
\n
(e) Commodity Price Risk
\n
The Group has no exposure to commodity price risk on its financial instruments at 30 June 2026. No hedging or
\n
derivative transactions have been used to manage commodity price risk.
\n
\n
Profit or loss
\n
Other Comprehensive Income
\n
\n
+ 300 basis
\n
points
\n
$
\n
- 300 basis
\n
points
\n
$
\n
+ 300 basis
\n
points
\n
$
\n
- 300 basis
\n
points
\n
$
\n
\n
\n
\n
\n
\n
2026
\n
\n
\n
\n
\n
Group
\n
\n
\n
\n
\n
Cash and cash equivalents
\n
691,592
\n
(113,455)
\n
-
\n
-
\n
\n
\n
\n
\n
\n
2025
\n
\n
\n
\n
\n
Group
\n
\n
\n
\n
\n
Cash and cash equivalents
\n
204,852
\n
(204,727)
\n
-
\n
-
\n
\n\n
\n
(f) Capital Management
\n
The Group defines its Capital as total equity of the Group, being $18,076,853 as at 30 June 2026 (2025: $14,322,747).
\n
The Group manages its capital to ensure that entities in the Group will be able to continue as a going concern
\n
while financing the development of its projects through primarily equity based financing. The Board's policy is to
\n
maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future
\n
development of the business. Given the stage of development of the Group, the Board's objective is to minimise
\n
debt and to raise funds as required through the issue of new shares.
\n
The Group is not subject to externally imposed capital requirements.
\n
There were no changes in the Group's approach to capital management during the year. During the next 12
\n
months, the Group will continue to explore project financing opportunities, primarily consisting of additional issues
\n
of equity.
\n
\n\n
\n
(g) Foreign Currency Risk
\n
The Group has transactional currency exposures. Such exposure arises from transactions denominated in
\n
currencies other than the functional currency of the entity.
\n
The Group\u2019s exposure to foreign currency risk throughout the current and prior year primarily arose from
\n
controlled entities of the Company whose functional currency is in Euros (EUR) and the Polish Zloty (PLN) and
\n
contractual obligations in Great British Pound (GBP).
\n
It is the Group\u2019s policy not to enter into any hedging or derivative transactions to manage foreign currency risk.
\n
However, the Group does hold some PLN cash and cash equivalents to fund its planned Polish operations over the
\n
next 12 months, given the majority of the Group\u2019s expenditure over this period is expected to be in PLN.
\n
At the reporting date, the Group\u2019s exposure to financial instruments denominated in foreign currencies was:
\n
\n\n
\n\n\n
\n\n
\n
2026
\n
PLN
\n
GBP
\n
EUR
\n
Equivalent
\n
AUD
\n
AUD
\n
Total
\n
Equivalent
\n
AUD
\n
Financial assets
\n
\n
\n
\n
\n
\n
\n
Cash and cash equivalents
\n
126,137
\n
-
\n
24,343
\n
88,630
\n
13,328,815
\n
13,417,445
\n
Trade and other receivables
\n
88,543
\n
-
\n
9,674
\n
34,007
\n
511,521
\n
545,528
\n
Other
\n
-
\n
107,675
\n
-
\n
206,432
\n
-
\n
206,432
\n
\n
214,680
\n
107,675
\n
34,017
\n
329,069
\n
13,840,336
\n
14,169,405
\n
\n
\n
\n
\n
\n
\n
\n
Financial liabilities
\n
\n
\n
\n
\n
\n
\n
Trade and other payables
\n
(185,503)
\n
-
\n
(84,490)
\n
(210,671)
\n
(2,763,387)
\n
(2,974,058)
\n
\n
(185,503)
\n
-
\n
(84,490)
\n
(210,671)
\n
(2,763,387)
\n
(2,974,058)
\n
Net exposure
\n
29,177
\n
107,675
\n
(50,473)
\n
118,398
\n
11,076,949
\n
11,195,347
\n
\n
Foreign exchange rate sensitivity
\n
At the reporting date, had the Australian Dollar appreciated or depreciated against the PLN and GBP, as illustrated
\n
in the table below, Profit or Loss and other Comprehensive Income would have been affected by the amounts
\n
shown below. This analysis assumes that all other variables remain constant.
\n
\n
Profit or loss
\n
Other Comprehensive Income
\n
\n
10% Increase
\n
10% Decrease
\n
10% Increase
\n
10% Decrease
\n
\n
\n
\n
\n
\n
2026
\n
\n
\n
\n
\n
Group
\n
\n
\n
\n
\n
AUD to PLN
\n
1,121
\n
(1,121)
\n
-
\n
-
\n
AUD to GBP
\n
20,643
\n
(20,643)
\n
-
\n
-
\n
AUD to EUR
\n
(8,327)
\n
8,327
\n
-
\n
-
\n
\n\n
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag380": {
"value": "\n(b) Credit Risk
\nCredit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to
\nmeet its contractual obligations. This arises principally from cash and cash equivalents and trade and other
\nreceivables. There are no significant concentrations of credit risk within the Group. The carrying amount of the
\nGroup's financial assets represents the maximum credit risk exposure, as represented below:
\n
\n\n\n
\n2026
\n2025
\n
\n$
\n$
\nCash and cash equivalents
\n13,417,445
\n6,826,337
\nTrade and other receivables
\n545,528
\n559,586
\n
\n13,962,973
\n7,385,923
\nWith respect to credit risk arising from cash and cash equivalents, the Group's exposure to credit risk arises from
\ndefault of the counter party, with a maximum exposure equal to the carrying amount of these instruments. Where
\npossible, the Group invests its cash and cash equivalents with banks that are rated the equivalent of investment
\ngrade and above. The Group\u2019s exposure and the credit ratings of its counterparties are continuously monitored
\nand the aggregate value of transactions concluded is spread amongst approved counterparties.
\nThe Group does not have any significant customers and accordingly does not have significant exposure to bad or
\ndoubtful debts.
\nTrade and other receivables comprise trade and other receivables, interest accrued and GST refunds due.
\nReceivable balances are monitored on an ongoing basis with the result that the Group\u2019s exposure to impairment
\nis not significant. At 30 June 2026, none (2025: none) of the Group\u2019s receivables are impaired.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfCreditRiskExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag383": {
"value": "\n(c) Liquidity Risk
\nLiquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. The Board's
\napproach to managing liquidity is to ensure, as far as possible, that the Group will always have sufficient liquidity
\nto meet its liabilities when due. At 30 June 2026 and 2025, the Group had sufficient liquid assets to meet its financial
\nobligations.
\nThe contractual maturities of financial liabilities, including estimated interest payments, are provided below. There
\nare no netting arrangements in respect of financial liabilities.!
\n
\n\u22646 Months
\n$
\n6-12 Months
\n$
\n1-5 Years
\n$
\n\u22655 Years
\n$
\nTotal
\n$
\n2026
\n
\n
\n
\n
\n
\nFinancial Liabilities
\n
\n
\n
\n
\n
\nTrade and other payables
\n2,318,612
\n-
\n-
\n-
\n2,318,612
\nOther financial liabilities
\n128,643
\n134,965
\n367,148
\n-
\n630,756
\n
\n2,447,255
\n134,965
\n367,148
\n-
\n2,949,368
\n2025
\n
\n
\n
\n
\n
\nFinancial Liabilities
\n
\n
\n
\n
\n
\nTrade and other payables
\n2,347,703
\n-
\n-
\n-
\n2,347,703
\nOther financial liabilities
\n-
\n-
\n-
\n-
\n-
\n
\n2,347,703
\n
\n-
\n-
\n2,347,703
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfLiquidityRiskExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag384": {
"value": "\n(d) Interest Rate Risk
\nThe Group's exposure to the risk of changes in market interest rates relates primarily to the cash and short-term
\ndeposits with a variable interest rate.
\nThese financial assets with variable rates expose the Group to cash flow interest rate risk. All other financial assets
\nand liabilities, in the form of receivables and payables are non-interest bearing.
\nAt the reporting date, the Group's exposure to variable interest rates was:
\n
\n2026
\n2025
\n
\n$
\n$
\nInterest-bearing financial instruments
\n
\n
\nCash at bank and on hand
\n7,417,445
\n6,826,337
\nBank short term deposits
\n6,000,000
\n-
\n
\n13,417,445
\n6,826,337
\nThe Group's cash at bank and on hand and short term deposits had a weighted average floating interest rate at
\nyear end of 2.22 % (2025: 3.99%).
\nThe Group currently does not engage in any hedging or derivative transactions to manage interest rate risk.
\n
\n\n\nInterest rate sensitivity
\nA sensitivity of 3% (300 basis points) has been selected as this is considered reasonable given the current level of
\nboth short term and long term interest rates. A 3% (300 basis points) movement in interest rates at the reporting
\ndate would have increased/(decreased) Profit or Loss and Other Comprehensive Income by the amounts shown
\nbelow. This analysis assumes that all other variables, in particular foreign currency rates, remain constant. The
\nanalysis is performed on a sensitivity of 3% (300 basis points) basis for 2026.
\n(e) Commodity Price Risk
\nThe Group has no exposure to commodity price risk on its financial instruments at 30 June 2026. No hedging or
\nderivative transactions have been used to manage commodity price risk.
\n
\nProfit or loss
\nOther Comprehensive Income
\n
\n+ 300 basis
\npoints
\n$
\n- 300 basis
\npoints
\n$
\n+ 300 basis
\npoints
\n$
\n- 300 basis
\npoints
\n$
\n
\n
\n
\n
\n
\n2026
\n
\n
\n
\n
\nGroup
\n
\n
\n
\n
\nCash and cash equivalents
\n691,592
\n(113,455)
\n-
\n-
\n
\n
\n
\n
\n
\n2025
\n
\n
\n
\n
\nGroup
\n
\n
\n
\n
\nCash and cash equivalents
\n204,852
\n(204,727)
\n-
\n-
\n
\n\n\n(g) Foreign Currency Risk
\nThe Group has transactional currency exposures. Such exposure arises from transactions denominated in
\ncurrencies other than the functional currency of the entity.
\nThe Group\u2019s exposure to foreign currency risk throughout the current and prior year primarily arose from
\ncontrolled entities of the Company whose functional currency is in Euros (EUR) and the Polish Zloty (PLN) and
\ncontractual obligations in Great British Pound (GBP).
\nIt is the Group\u2019s policy not to enter into any hedging or derivative transactions to manage foreign currency risk.
\nHowever, the Group does hold some PLN cash and cash equivalents to fund its planned Polish operations over the
\nnext 12 months, given the majority of the Group\u2019s expenditure over this period is expected to be in PLN.
\nAt the reporting date, the Group\u2019s exposure to financial instruments denominated in foreign currencies was:
\n
\n\n\n
\n2026
\nPLN
\nGBP
\nEUR
\nEquivalent
\nAUD
\nAUD
\nTotal
\nEquivalent
\nAUD
\nFinancial assets
\n
\n
\n
\n
\n
\n
\nCash and cash equivalents
\n126,137
\n-
\n24,343
\n88,630
\n13,328,815
\n13,417,445
\nTrade and other receivables
\n88,543
\n-
\n9,674
\n34,007
\n511,521
\n545,528
\nOther
\n-
\n107,675
\n-
\n206,432
\n-
\n206,432
\n
\n214,680
\n107,675
\n34,017
\n329,069
\n13,840,336
\n14,169,405
\n
\n
\n
\n
\n
\n
\n
\nFinancial liabilities
\n
\n
\n
\n
\n
\n
\nTrade and other payables
\n(185,503)
\n-
\n(84,490)
\n(210,671)
\n(2,763,387)
\n(2,974,058)
\n
\n(185,503)
\n-
\n(84,490)
\n(210,671)
\n(2,763,387)
\n(2,974,058)
\nNet exposure
\n29,177
\n107,675
\n(50,473)
\n118,398
\n11,076,949
\n11,195,347
\n\n
Foreign exchange rate sensitivity
\n
At the reporting date, had the Australian Dollar appreciated or depreciated against the PLN and GBP, as illustrated
\n
in the table below, Profit or Loss and other Comprehensive Income would have been affected by the amounts
\n
shown below. This analysis assumes that all other variables remain constant.
\n
\n
Profit or loss
\n
Other Comprehensive Income
\n
\n
10% Increase
\n
10% Decrease
\n
10% Increase
\n
10% Decrease
\n
\n
\n
\n
\n
\n
2026
\n
\n
\n
\n
\n
Group
\n
\n
\n
\n
\n
AUD to PLN
\n
1,121
\n
(1,121)
\n
-
\n
-
\n
AUD to GBP
\n
20,643
\n
(20,643)
\n
-
\n
-
\n
AUD to EUR
\n
(8,327)
\n
8,327
\n
-
\n
-
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfMarketRiskExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag387": {
"value": "\n(f) Capital Management
\nThe Group defines its Capital as total equity of the Group, being $18,076,853 as at 30 June 2026 (2025: $14,322,747).
\nThe Group manages its capital to ensure that entities in the Group will be able to continue as a going concern
\nwhile financing the development of its projects through primarily equity based financing. The Board's policy is to
\nmaintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future
\ndevelopment of the business. Given the stage of development of the Group, the Board's objective is to minimise
\ndebt and to raise funds as required through the issue of new shares.
\nThe Group is not subject to externally imposed capital requirements.
\nThere were no changes in the Group's approach to capital management during the year. During the next 12
\nmonths, the Group will continue to explore project financing opportunities, primarily consisting of additional issues
\nof equity.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag391": {
"value": "\nForeign exchange rate sensitivity
\nAt the reporting date, had the Australian Dollar appreciated or depreciated against the PLN and GBP, as illustrated
\nin the table below, Profit or Loss and other Comprehensive Income would have been affected by the amounts
\nshown below. This analysis assumes that all other variables remain constant.
\n
\nProfit or loss
\nOther Comprehensive Income
\n
\n10% Increase
\n10% Decrease
\n10% Increase
\n10% Decrease
\n
\n
\n
\n
\n
\n2026
\n
\n
\n
\n
\nGroup
\n
\n
\n
\n
\nAUD to PLN
\n1,121
\n(1,121)
\n-
\n-
\nAUD to GBP
\n20,643
\n(20,643)
\n-
\n-
\nAUD to EUR
\n(8,327)
\n8,327
\n-
\n-
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag392": {
"value": "\n
\n\n
23. CONTINGENT ASSETS AND LIABILITIES
\n
Arbitration Award
\n
In October 2024, an independent Tribunal unanimously held that Poland had breached its obligations under the
\n
BIT and ECT treaties in relation to the Jan Karski project, entitling GreenX to compensation. The Company has
\n
been awarded a total of up to \u00a3252m (A$495m / PLN1.3bn) in compensation by the Tribunal, plus interest of
\n
approximately six per cent per annum based on today\u2019s rates (SONIA plus one per cent) until full and final
\n
satisfaction of the award by Poland. Interest of approximately \u00a312 million (A$28 million / PLN 70 million) per annum
\n
is currently continuing to accrue.
\n
All of GreenX\u2019s costs associated with the arbitration claim were funded on a limited basis from Litigation Capital
\n
Management (LCM). To date, GreenX has drawn down US$11.3 million from LCM. Once the award compensation is
\n
received from Poland, LCM will be entitled to be paid back the US$11.3 million of funding, a multiple of five times
\n
of the US$11.3 million and, from 1 January 2025, interest on the US$11.3 million at a rate of 30% per annum,
\n
compounding monthly (which equates to interest of approximately US$3.4 million (\u00a32.7 million / A$5.5 million /
\n
PLN 13.5 million) per annum). Net of the payments to LCM, GreenX will pay six per cent of the balance of the award
\n
compensation to key management directly involved in the case (as previously approved by shareholders on 20
\n
January 2021) and three per cent to key legal advisers who assisted with the case on a reduced and fixed fee.
\n
In November 2024, Poland lodged a request to set-aside the BIT award in the courts of England and Wales and in
\n
January 2025 Poland has lodged a request to set-aside the ECT award in the Singapore Courts. The Company is
\n
currently strongly defending the set-aside motions. In January 2026, the Singapore Court issued a judgment
\n
whereby it rejected, in its entirety, Poland\u2019s application to set aside the ECT award. Poland has since applied to the
\n
Court of Appeal of the Republic of Singapore to appeal the Singapore Courts dismissal of its ECT set-aside motion.
\n
The appeal has now been heard by the Court of Appeal, with its decision pending. The Court of Appeal represents
\n
Poland\u2019s final level of appeal within the Singapore courts for the ECT set-aside motion.
\n
Whilst the Company is confident in the strength of the award, as reflected in the unanimous tribunal decision and
\n
the Singapore Courts initial dismissal of Poland\u2019s ECT set-aside motion, the Company has not recognised an asset
\n
or any corresponding liabilities in relation to the award at 30 June 2026 while the set-aside motions and appeals
\n
are ongoing and the outcome is not yet known. Accordingly, the final outcome and payment of the award is not
\n
virtually certain which does not meet the recognition requirements for AASB 137, Provisions, Contingent Liabilities
\n
and Contingent Assets. The Award has therefore been classified as a contingent asset with the related liabilities
\n
recognised as a contingent liability.
\n
\n\n
\n\n\n
\n\n
Tannenberg
\n
On 2 August 2024, GreenX entered into the JVA with Group 11 through which GreenX could earn a 90% interest in
\n
Tannenberg. As a result of the progress made on the Project to date, GreenX has elected to acquire 90% of the fully
\n
diluted share capital of Group 11. Under the terms of the JVA, if a scoping study is published by GreenX on the ASX
\n
regarding the Tannenberg license area (or area of influence) on or before 1 August 2029, GreenX must issue the
\n
vendor 5 million shares on the completion of the first such scoping study. As there is a possible obligation that will
\n
only be confirmed by uncertain future events, which is within the control of the Company, the deferred share
\n
payment for Tannenberg has been classified as a contingent liability.
\n
\n\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag393": {
"value": "\n23. CONTINGENT ASSETS AND LIABILITIES
\nArbitration Award
\nIn October 2024, an independent Tribunal unanimously held that Poland had breached its obligations under the
\nBIT and ECT treaties in relation to the Jan Karski project, entitling GreenX to compensation. The Company has
\nbeen awarded a total of up to \u00a3252m (A$495m / PLN1.3bn) in compensation by the Tribunal, plus interest of
\napproximately six per cent per annum based on today\u2019s rates (SONIA plus one per cent) until full and final
\nsatisfaction of the award by Poland. Interest of approximately \u00a312 million (A$28 million / PLN 70 million) per annum
\nis currently continuing to accrue.
\nAll of GreenX\u2019s costs associated with the arbitration claim were funded on a limited basis from Litigation Capital
\nManagement (LCM). To date, GreenX has drawn down US$11.3 million from LCM. Once the award compensation is
\nreceived from Poland, LCM will be entitled to be paid back the US$11.3 million of funding, a multiple of five times
\nof the US$11.3 million and, from 1 January 2025, interest on the US$11.3 million at a rate of 30% per annum,
\ncompounding monthly (which equates to interest of approximately US$3.4 million (\u00a32.7 million / A$5.5 million /
\nPLN 13.5 million) per annum). Net of the payments to LCM, GreenX will pay six per cent of the balance of the award
\ncompensation to key management directly involved in the case (as previously approved by shareholders on 20
\nJanuary 2021) and three per cent to key legal advisers who assisted with the case on a reduced and fixed fee.
\nIn November 2024, Poland lodged a request to set-aside the BIT award in the courts of England and Wales and in
\nJanuary 2025 Poland has lodged a request to set-aside the ECT award in the Singapore Courts. The Company is
\ncurrently strongly defending the set-aside motions. In January 2026, the Singapore Court issued a judgment
\nwhereby it rejected, in its entirety, Poland\u2019s application to set aside the ECT award. Poland has since applied to the
\nCourt of Appeal of the Republic of Singapore to appeal the Singapore Courts dismissal of its ECT set-aside motion.
\nThe appeal has now been heard by the Court of Appeal, with its decision pending. The Court of Appeal represents
\nPoland\u2019s final level of appeal within the Singapore courts for the ECT set-aside motion.
\nWhilst the Company is confident in the strength of the award, as reflected in the unanimous tribunal decision and
\nthe Singapore Courts initial dismissal of Poland\u2019s ECT set-aside motion, the Company has not recognised an asset
\nor any corresponding liabilities in relation to the award at 30 June 2026 while the set-aside motions and appeals
\nare ongoing and the outcome is not yet known. Accordingly, the final outcome and payment of the award is not
\nvirtually certain which does not meet the recognition requirements for AASB 137, Provisions, Contingent Liabilities
\nand Contingent Assets. The Award has therefore been classified as a contingent asset with the related liabilities
\nrecognised as a contingent liability.
\n
\n\n\nTannenberg
\nOn 2 August 2024, GreenX entered into the JVA with Group 11 through which GreenX could earn a 90% interest in
\nTannenberg. As a result of the progress made on the Project to date, GreenX has elected to acquire 90% of the fully
\ndiluted share capital of Group 11. Under the terms of the JVA, if a scoping study is published by GreenX on the ASX
\nregarding the Tannenberg license area (or area of influence) on or before 1 August 2029, GreenX must issue the
\nvendor 5 million shares on the completion of the first such scoping study. As there is a possible obligation that will
\nonly be confirmed by uncertain future events, which is within the control of the Company, the deferred share
\npayment for Tannenberg has been classified as a contingent liability.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
},
"Tag396": {
"value": "\n24. EVENTS SUBSEQUENT TO BALANCE DATE
\nOn 4 August 2026, the Company announced the grant of two additional exploration licences at Eleonore North.
\nThe Company has secured exclusive rights to ~1,600 km
\n2
\n of tenure prospective for RIRGS. These new licences
\ncomplement the Company\u2019s existing licences located 100 km to the north.
\nThere are no other matters or circumstances, which have arisen since 30 June 2026 that have significantly affected
\nor may significantly affect:
\n\u2022 the operations, in financial years subsequent to 30 June 2026 of the Consolidated Entity;
\n\u2022 the results of those operations, in financial years subsequent to 30 June 2026, of the Consolidated Entity; or
\n\u2022 the state of affairs, in financial years subsequent to 30 June 2026, of the Consolidated Entity.
\n
\n\n",
"dimensions": {
"concept": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
"language": "en",
"entity": "scheme:213800EHCGNYSCN9T108",
"period": "2025-07-01T00:00:00/2026-07-01T00:00:00"
}
}
}
}